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Since large amounts of biological data are generated using various high-
throughput technologies, efficient computational methods are important for 
understanding the biological meanings behind the complex data. Machine learning is 
particularly appealing for biological knowledge discovery. Tissue-specific gene 
expression and protein sumoylation play essential roles in the cell and are implicated in 
many human diseases. Protein destabilization is a common mechanism by which 
mutations cause human diseases. In this study, machine learning approaches were 
developed for predicting human tissue-specific genes, protein sumoylation sites and 
protein stability changes upon single amino acid substitutions. Relevant biological 
features were selected for input vector encoding, and machine learning algorithms, 
including Random Forests and Support Vector Machines, were used for classifier 
construction. The results suggest that the approaches give rise to more accurate 
predictions than previous studies and can provide valuable information for further 
experimental studies. Moreover, seeSUMO and MuStab we  servers were developed to 
make the classifiers accessible to the biological research community. 
Structure-based methods can be used to predict the effects of amino acid 
substitutions on protein function and stability. The nonsynonymous Single Nucleotide 
Polymorphisms (nsSNPs) located at the protein binding interface have dramatic effects 
on protein-protein interactions. To model the effects, the nsSNPs at the interfaces of 264 
protein-protein complexes were mapped on the protein structures using homology-based 
methods. The results suggest that disease-causing nsSNPs tend to destabilize the 
 iii
electrostatic component of the binding energy and nsSNPs at conserved positions have 
significant effects on binding energy changes. The structure-based approach was 
developed to quantitatively assess the effects of amino acid substitutions on protein 
stability and protein-protein interaction. It was shown that the structure-based analysis 
could help elucidate the mechanisms by which mutations cause human genetic disorders. 
These new bioinformatic methods can be used to analyze some interesting genes and 
proteins for human genetic research and improve our understanding of their molecular 
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With the development of various genome sequencing projects and high-
throughput technologies, modern biology has entered into a “data explosion” era. 
However, such large amounts of biological data bring the so-called "data rich, 
information poor" problem. On one hand, more and more biological data are generated by 
experimental studies, ranging from genomics to proteomics. On the other hand, it is not 
easy to extract useful information from the biological data, and the underlying molecular 
mechanisms remain elusive. There is a significant need for developing efficient 
computational methods to discover biological knowledg  hidden in the massive and 
heterogeneous datasets. 
Machine learning is a broad research field with wide applications in business, 
engineering and science. It focuses on designing and developing computer algorithms to 
improve predictive performance based on training data instances. Machine learning 
approaches such as Bayesian Networks, Hidden Markov Models, Neural Networks and 
Genetic Programming have been applied to various scientific fields including natural 
language processing, computer vision, search engine dev lopment, medical diagnosis and 
bioinformatics [1]. Machine learning can be used to recognize hidden patterns in data, 
and thus is particularly appealing for biological knowledge discovery in bioinformatic 
studies. There are different types of learning including unsupervised learning and 
supervised learning. Unsupervised learning can discover unknown clusters or detect 
anomalies from unlabeled data instances. It has been us d to analyze genes associated 
1 
 2 
with human diseases. For example, clustering methods ave been applied to analyses of 
gene expression data from different cancer samples including breast tumour samples [2], 
prostate cancer samples [3] and colon cancer samples [4]. By contrast, the training data 
instances used for supervised learning are labeled with the known information. 
Supervised learning can recognize hidden patterns in the labeled examples, and the 
resulting model can be used to make predictions for new data instances. It has been 
utilized for analyzing some important protein functions, such as protein secondary 
structures [5], functional residues [6], protein stability [7]  and protein-protein interaction 
networks [8].  
Supervised machine learning algorithms such as Support Vector Machines 
(SVMs) and Random Forests (RFs) have found wide applications in bioinformatic 
studies. SVMs can transform the training data into a feature space using kernel functions 
and then separate the data by a maximum-margin hyperplan  [9]. SVMs have been used 
for predicting DNA/RNA-binding residues [10, 11], protein-protein interaction [12], 
subcellular localization [13] and protein stability changes upon mutations [14]. RFs are 
ensemble learning algorithms which can handle a large number of input variables and 
avoid model overfitting. It combines the votes made by the independent decision trees, 
and gives the most popular class as the output. RFs are becoming popular in various 
bioinformatic fields including structure classification [15], protein interaction site 
prediction [16], DNA-binding residues identification [17] and drug sensitivity prediction 
[18].  
 3 
Tissue-specific gene plays a key role in the pathogenesis of many human diseases 
[19]. Several statistical approaches, including Akaike’s information criterion [20], 
Shannon entropy [6] and  hypothesis testing [21], have been utilized for identifying the 
tissue-specific genes using microarray expression data. However, the statistical methods 
assign an equal weight to each observation and do not use biological knowledge for 
predictions. A SVM-based approach has been developed to predict tissue-specific genes 
in Caenorhabditis elegans [22], but whether the machine learning methods can be used 
for predicting human tissue-specific genes is still unknown. Protein sumoylation is 
important for many cellular processes and any alterations in the process may cause 
various human diseases. Several computational methods such as SUMOpre [23], 
SUMOsp [24] and SUMOsp2.0 [25] have been developed for predicting sumoylation 
sites. To understand how a single amino acid substit tion changes protein stability can 
help elucidate the molecular mechanism by which the mutations cause human diseases. 
Machine learning approaches such as I-Mutant2.0 [14] and iPTREE-STAB [26] have 
recently been applied to sequence-based prediction of protein stability changes upon 
mutations. However, little domain-specific knowledg in terms of relevant biological 
features was used in the studies for analyzing protein functions. In this study, machine 
learning approaches were developed for predicting human tissue-specific genes (chapter 
two), protein sumoylation sites (chapter three) andprotein stability changes upon single 
amino acid substitutions (chapter four). 
Supervised learning algorithms, including RFs and SVMs, have new applications 
in the present study. RFs and SVMs were used to identify human tissue-specific genes 
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with microarray gene expression data and predict protein sumoylation sites from protein 
sequence information. RF classifiers were found to outperform SVM models, and the 
approaches can provide useful information for further experimental studies. Furthermore, 
SVMs were applied to sequence-based prediction of protein stability changes upon amino 
acid substitutions. The supervised learning algorithms were used to develop seeSUMO 
(http://bioinfo.ggc.org/seesumo) and MuStab (http://bioinfo.ggc.org/mustab) web servers 
for predicting protein sumoylation sites and protein stability changes upon single amino 
acid substitutions, respectively. 
The novelty of our approach is that the biological knowledge was used for 
classifier construction. Relevant biological features can be selected to construct 
classifiers and improve the predictive performance of classifiers. For example, the use of 
biochemical features and evolutionary information for input vector encoding can 
significantly improve the predictive performance of DNA-binding site prediction [11]. In 
this study, relevant features representing biological knowledge were used to encode input 
variables for sequence-based predictions of protein sumoylation sites and protein stability 
changes upon single amino acid substitutions. It was shown that the use of relevant 
biological features for classifier construction can significantly improve the predictive 
performances of classifiers.  
The improvement of experimental determination of protein 3D structures and 
computational modeling [27, 28] made it possible to predict the effects of mutations by 
mapping them on the corresponding structures or models. Protein structural information 
has been used in many studies to reveal the role of amino acid substitutions on protein 
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function and stability. Previous studies on human no -synonymous Single Nucleotide 
Polymorphisms (nsSNP) in disease candidate genes rev aled that approximately 70% of 
the deleterious mutations are located in the structu ally and/or functionally important 
sites [29-32]. A structure-based approach that models r sidue-residue interaction 
networks was developed recently [33], and graph theoretical measures were used to 
predict the residues that are important for structural stability. The results suggest that 
mutations impact protein function and stability by affecting their structures, which in turn 
may cause changes in protein-protein interactions.  
It has been estimated that each person may have 24,000 - 40,000 nsSNPs, and 
there are a total of 67,000 - 200,000 common nsSNPs in the human population [34]. 
Previous study suggest that approximately 25% of nsSNPs in the human population 
might be deleterious to protein function [35], and 88% of disease-associated nsSNPs are 
located in the voids/pockets important for protein-protein interactions [32]. The nsSNPs 
located at the binding interface or active site cleft may cause a series of changes, such as 
disruption of salt bridges, breakage of hydrogen bods and alteration of binding affinity. 
In chapter five, we investigated the effects of nsSNPs at the interfaces of 264 protein-
protein complexes using a structure-based method. The nsSNPs were mapped on the 
protein structures and their effects on the binding energy were investigated with 
CHARMM force field and continuum electrostatic calculation. The findings reveal that 
disease-causing nsSNPs tend to destabilize the electrostatic component of the binding 
energy on protein-protein interactions and nsSNPs at conserved positions can lead to a 
large variance of the binding energy changes.  
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The sequence/structure-based computational methods developed in this study can 
be used to analyze proteins, in which mutations maycause human genetic disorders such 
as intellectual disability. Intellectual disability is the most frequent developmental 
disability with an estimated incidence of 1-3% of peo le worldwide. It is often caused by 
loss-of-function mutations in associated genes. For example, several deleterious 
mutations in the spermine synthase (SMS) gene were found to cause Snyder-Robinson 
syndrome, an X-linked recessive disease with mild-to-moderate intellectual disability 
[36]. Recently, a structure-based approached was utilized to predict the effects of three 
missense SMS mutations causing Snyder-Robinson syndrome on protein stability, 
flexibility and interactions [37]. In chapter six, the structure-based approach is described 
for quantitatively assessing the effects of amino acids on protein stability and protein-
protein interaction using homology modeling and free energy calculation methods. The 
results suggest that the structure-based approach tgether with sequence-based methods 
can provide useful information for characterizing mutations associated with intellectual 
disability in human genetic studies and elucidating he molecular mechanisms by which 
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A MACHINE LEARNING APPROACH FOR PREDICTING HUMAN TISSUE-
SPECIFIC GENES USING MICROARRAY EXPRESSION DATA1 
 
ABSTRACT 
Understanding how genes are expressed specifically in particular tissues is a 
fundamental question in developmental biology. Many tissue-specific genes are involved 
in the pathogenesis of complex human diseases. However, xperimental identification of 
tissue-specific genes is time consuming and difficult. The accurate predictions of tissue-
specific gene targets could provide useful information for biomarker development and 
drug target identification. In this study, we have developed a machine learning approach 
for predicting the human tissue-specific/selective genes using microarray expression data. 
The lists of known tissue-specific genes for different tissues were collected from UniProt 
database, and the expression data retrieved from the previously compiled dataset 
according to the lists were used for input vector encoding. Random Forests (RFs) and 
Support Vector Machines (SVMs) were used to construct accurate classifiers. The RF 
classifiers were found to outperform SVM models for tissue-specific gene prediction. The 
results suggest that the candidate genes for brain o  l ver specific expression can provide 
valuable information for further experimental studies. Our approach was also applied for 
identifying tissue-selective gene targets for different types of tissues. The approach 
provides an efficient way to select some interesting genes for developing new biomedical 
markers and improve our knowledge of tissue-specific expression. 
                                                  
1Teng S, Wang L: A machine learning approach for predicting human tissue-specific genes using 
microarray expression data, in preparation. 
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BACKGROUND 
Understanding how different tissues achieve specificity s a fundamental question 
in tissue ontogenesis and evolution. Some genes are highly expressed in a particular 
tissue and lowly expressed or not expressed in other tissues. These genes are generally 
called tissue-selective genes. The genes are responsible for specialized functions in 
particular tissues, and thus can serve as the biomarkers for specific biological processes. 
In addition, many tissue-selective genes are involved in the pathogenesis of complex 
human diseases [1], including insulin signaling pathways in diabetes [2] and tumour–host 
interactions in cancer [3]. Since the majority of disease genes have the tendency to be 
expressed preferentially in particular tissues [4], identifying tissue-selective genes is also 
important for drug target selection in biomedical research. Tissue-specific genes, which 
are expressed specifically in a particular tissue, ar  regarded as the special case of tissue 
selective genes. The identification of tissue-specific genes could help biologists to 
elucidate the molecular mechanisms of tissue development and provide valuable 
information for identifying candidate biomarkers and drug targets. 
Different methods have been proposed to identify and characterize tissue-specific 
genes. Traditional experimental technologies, including RT-PCR and Northern blot, are 
usually carried out at the single-gene level and thus time-consuming. High-throughput 
technologies, such as Expressed Sequence Tag (EST) sequencing and DNA microarrays, 
have the capacity to perform genome-wide analysis with high efficiency. The DNA 
microarray technology can generate large amounts of gene expression data from various 
tissues, and provide the useful data source for analyzi g tissue-specific genes. Several 
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statistical methods have been applied for identifyig tissue-specific genes using gene 
expression data.  Kadota and co-workers [5] described an unsupervised method to select 
the tissue-specific genes using Akaike’s information criterion (AIC) approach. Another 
method called ROKU [6] has been developed by the same group for detecting tissue-
specific gene expression patterns. The approach used Shannon entropy and outlier 
detection to scan expression profiles for ranking tissue-specific genes. Liang et al. [7] 
developed a statistical method based on hypothesis t ting procedures to profile and 
identify the tissue-selective genes. However, the statistical methods for tissue-specific 
gene prediction suffer from drawbacks. The microarray expression data are generated 
from different experiments, both biological variations and experimental noise result in 
significant variations in data quality. The statistical methods usually assigned an equal 
weight to each observation for prediction. Thus, the methods do not work well for non-
linear models and may not detect the hidden expression patterns from the noisy 
microarray data. Moreover, the statistical methods do not use biological knowledge for 
prediction. The simple data-driven analysis may produce some misleading results for 
further experimental studies. 
Machine learning can automatically recognize hidden patterns in complex data. It 
has been shown that machine learning can be used to construct accurate classifiers for 
tissue-specific gene prediction. Chikina et al [8] used Support Vector Machines (SVMs) 
to predict tissue-specific gene expression in Caenorhabditis elegans with whole-animal 
microarray data. The SVM classifiers reached high predictive performances in nearly all 
tissues. It was shown that the approach outperformed clustering methods and provided 
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valuable information for further experimental studies. However, it is still unknown 
whether machine learning methods can be used to predict tissue-specific genes in human. 
In a previous study [9],  a large dataset has been compiled from a compendium of 
microarray expression profiles collected from 131 microarray datasets in different 
studies. The integrated dataset contained 2,968 expression profiles for various human 
tissues including brain (616 profiles) liver (117 profiles), testis (36 profiles), blood (409 
profiles) and kidney (73 profiles). A computational method was developed for predicting 
tissue-selective genes with the integrated dataset using both microarray intensity values 
and detection calls. However, the method assigned a equal weight to each expression 
profile for prediction. In this study, a machine learning approach was developed for 
human tissue-specific gene prediction using the available dataset. According to the lists 
of known tissue-specific genes, the gene expression data were extracted from the 
compiled dataset and used for classifier construction. Random Forests (RFs) and Support 
Vector Machines (SVMs) were trained with the expression data to construct accurate 
classifiers. The results indicate that the RF classifier  achieved better predictive 
performance for tissue-specific gene prediction. The approach generated large numbers 
of candidate genes for brain and liver-specific expr ssion. The examinations of high 







A schematic diagram of the approach used in this study is shown in Figure 2.1. 
The microarray expression profiles of various human tissues were collected from NCBI 
GEO database [9]. The selected profiles were integra d into a single dataset through 
normalization and transformation. The lists of know tissue-specific genes were 
manually collected from UniProt database. The tissue- pecific gene expression data were 
extracted from the integrated single dataset and labelled as positive training instances.  
The remaining expression data were randomly divided into two subsets. The negative 
dataset contained tenfold number of data instances as the positive instances. Random 
Forests (RFs) and Support Vector Machines (SVMs) were trained with the training 
instances to construct classifiers. The tenfold cross-validation method was performed to 
evaluate the classifier performance. The models were then used to score the remaining 
data instances for prediction. The classifier construction and prediction were repeated ten 
times, and the candidate genes were prioritized according to their average classifier 




Figure 2.1 Schematic diagram of the approach for predicting tissue-specific genes. 
 
Microarray data collection and integration 
The approach for compiling human microarray expression profiles was described 
previously [9].  The microarray gene expression profiles of various human tissues from 
131 microarray studies were compiled from NCBI GEO database. The expression 
profiles were generated using the Affymetrix HG-U133 Plus 2.0 Array and obtained from 
normal tissue samples. The raw data in CEL file format were organized into different 
normalization groups and normalized using the dChip tool with the invariant set method 
[10]. The outlier array exclusion and global median transformation were used to integrate 
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the normalized microarray profiles into a single dataset. The dataset used in this study 
contained 54,613 probe sets and 2,968 expression profiles. 
 
Training data preparation 
Tissue-selective genes are defined as the genes whoe expression is enriched for 
one or a few similar tissue types. The genes were manually collected from the UniProt 
database. The particular tissue name was used as a query and the reviewed human genes 
were selected for preparation. The tissue-selective genes are defined as the genes that are 
expressed preferentially in a particular tissue from the descriptions of their annotations. 
Most of the genes are identified by the experimental methods, which are independent 
from the microarray expression data in the list. In this study, 408 brain-selective genes, 
96 liver-selective genes, 326 testis-selective genes, 324 blood-selective genes and 45 
kidney-selective genes were collected from UniProt da abase.  Tissue-specific genes, 
whose expression is specific to only one particular tissue type, are considered as the 
special case of tissue-selective genes. 289 brain-specific genes and 69 liver-specific genes 
were selected from the corresponding tissue-selective genes with the annotation that their 
expression is specific to only brain or liver. Tissue specific-genes are the focus of the 
present study.  
According to the known tissue-specific/selective gene lists, the tissue-
specific/selective gene expression data was retrievd from the integrated microarray 
dataset and labelled as the positive training instances. The probe sets with detectable 
expression signals in corresponding tissue samples w re selected for classifier 
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construction. For tissue-specific gene prediction, the expression values for 403 probe sets 
of brain-specific genes and 90 probe sets of liver-specific genes were used for input 
vector encoding. 692 probe sets of brain-selective genes, 150 probe sets of liver-selective, 
430 probe sets of testis-selective genes, 456 probe sets of blood-selective genes and 76 
probe sets of kidney-selective genes were used for tissue-selective gene prediction. 
The negative examples were defined as the genes that do not have preferential 
expression in particular tissues. For this study, we randomly selected the data instances 
from the remaining data and labelled as the negative training instances. The number of 
negative instances was set as tenfold with positive instances to make enough data 
instances for training. The negative and positive data instances were combined as the 
training dataset to construct classifiers using machine learning algorithms. The remaining 
probes were used as the candidate genes for prediction with the classifiers constructed 
from the training dataset. 
 
Random Forests 
The use of 2,968 expression profiles for input vector encoding gives the same 
number of input variables. One potential problem is model overfitting since there were 
only a small number of positive instances (probe sets of known tissue-specific genes) 
available for this study. The problem could be solved using the Random Forests (RFs) 
learning algorithm. A typical RF model is made up many independent decision trees 
constructed using bootstrap samples from the training data. During tree construction, m 
variables out of all the n input variables (m << n) are randomly selected at each node, and 
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the tree node are split using the selected m variables. The RF classifier then combines the 
votes made by the decision trees, and gives the most popular class as the output of the 
ensemble for classification. Because of the random feature selection, RFs could handle a 
large number of input variables and avoid model overfitting. In the present study, the 
randomForest package in R was used for classifier construction. The number of variables 
selected to split each node (mtry) was set to 6, and the number of trees to grow (ntree) 
was set to 1000. Other values of the mtry and ntree parameters for training were also 
examined, but did not result in significant improvement of classifier performance. 
 
Support vector machine training 
Support Vector Machines (SVMs) are computational algorithms that can learn 
from training examples for binary classification. SVM classifiers were constructed and 
compared with RF classifiers for identifying human tissue-specific genes. The SVM 
learning algorithm can be described by four basic concepts, including the separating 
hyperplane, the maximum-margin hyperplane, the soft margin, and the kernel function 
[11]. For a linear classification, the data instance in classifier is represented as an n-
dimensional vector, and an ( – 1) dimensional hyperplane is used to separate the positive 
instances from the negative ones. The SVMlight software package 
(http://svmlight.joachims.org/) was utilized to construct the SVM classifiers using the 
linear function in this study.  The polynomial and radial basis function (RBF) kernel 
functions were also examined for classifier constructions, but the classifiers did not 
achieve high predictive performances in cross-validation tests. 
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Classifier evaluation and prediction 
This study used a tenfold cross-validation method t evaluate classifier 
performance. Positive and negative instances were randomly distributed into ten folds. In 
each of the ten iterations, nine of the ten folds were used to train a classifier, and then the 
remaining one fold was used as the test data to evaluate the classifier. Since the dataset 
was imbalanced, the positive instances of training data were replicated to get the 
approximately equal number with the negative instances. However, the positive instances 
in the test data were not replicated. The predictions made for the test instances in all the 
























=  (2.4) 
where TP is the number of true positives; TN is the number of true negatives; FP is the 
number of false positives; and FN is the number of false negatives. For imbalanced 
datasets, above measures could be misleading. Thus, the Receiver Operating 
Characteristic (ROC) curve [12], which generated by varying the output threshold of a 
classifier and plotting the true positive rate (sensitivity) against the false positive rate (1 – 
specificity) for each threshold value, was used for classifier evaluation and comparison. 
Since the ROC curve of an accurate classifier is clo e to the left-hand and top borders of 
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the plot, the area under the curve (AUC) can be used a  a reliable measure of classifier 
performance [13]. The good classifiers have AUC values close to 1, whereas weak 
classifiers have AUC values near to 0.5.  
The classifier construction and prediction were repeated ten times. In each run, 
the performance of classifier was computed by above measures. The mean value and 
standard deviation of the measures in ten runs werecalculated to check the average levels 
and variations of classifier performances, respectiv ly. The classifier was used to 
evaluate the candidate genes for prediction. The tissue-specific gene targets were sorted 
according to the decreasing average value of classifier outputs from ten predictions, and a 
higher value indicates a higher probability of being expressed predominantly in a 
particular tissue.  
 
RESULTS AND DISCUSSION 
Dataset validation 
The known tissue-specific genes are expressed predominantly in particular 
tissues, so the transcripts of the genes were expected to be detected in corresponding 
tissue samples in the integrated microarray dataset. To visualize the expression patterns 
of the known tissue-specific genes, TM4 MeV [14] was used to generate the heat maps 
for brain and liver-specific genes. As shown in Figure 2.2, the known brain-specific 
genes have expression patterns in brain as well as retina samples. Since retina shares the 
common embryonic origins with brain and translates the visual images into nerve signals 
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for brain, the retina is considered as the sensory pa t of the brain. Thus, the known brain-
specific genes may also have some expression levels in retina samples. 
The transcripts of known liver-specific genes are detected clearly in liver samples 
(Figure 2.2). The results suggest that the expression data according to our lists of known 
tissue-specific genes can provide useful information f r classifier construction using 
machine learning methods. It is noteworthy that some probe sets of known tissue-specific 
genes have high expression or no expression for all tissue samples. To improve the 
quality of classifiers, the probes without detectable expression signals in all the samples 
are excluded from the training dataset. 
 
 
Figure 2.2 Visualization of known tissue-specific gene expression patterns. 
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Prediction of tissue-specific genes 
Random Forests (RFs) and Support Vector Machines (SVMs) were used to 
construct classifiers for predicting brain and liver-tissue specific genes. The results 
suggest that RF classifiers reached better predictive performance than SVM models 
(Table 2.1 and Figure 2.3). We identified 1,408 brain-specific gene targets and 493 liver-
specific gene targets using RF classifiers (Appendix B), which are even more than tissue-
selective genes identified in the  previous study (222 brain-selective targets and 69 liver-
selective targets) [9]. It was shown that the transcripts of candidate genes could be 
detected clearly in corresponding tissue samples (Figure 2.4), and the functions of 
predicted targets were consistent with tissue origins in GO enrichment analysis (Table 2.2 
and 2.4). High scoring gene targets with brain or liver-specific expression have been 
examined (Table 2.3 and 2.5), and the results suggest that the approach can provide 
useful information for identification of novel gene targets in biomedical research.  
In this study, we constructed both RF and SVM classifier  for predicting brain 
and liver-specific genes. 403 probe sets of brain-specific genes and 90 probe sets of liver-
specific genes were used for classifier construction. For brain-specific gene prediction, 
the RF classifier achieved the AUC value at 0.9488 (Table 2.1), which is significantly 
higher than the AUC value of SVM classifier (AUC = 0.8937). The RF classifier reached 
53.73% sensitivity and 97.43% specificity, and MCC = 0.5676.  For liver-specific gene 
prediction, the SVM classifier gave MCC = 0.8350 and ROC AUC = 0.9854. The RF 
classifier achieved a similar level of performance with MCC = 0.8290 and ROC AUC = 
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0.9777. Thus, the results suggest that the RF algorithm performs better for predicting 
tissue-specific genes in this study. 
 
Table 2.1 Comparison of Random Forest and Support Vector Machine classifiers for 
predicting tissue-specific genes. The values outside and inside brackets are the average 
value and standard deviation of measures in ten classifier evaluations, respectively. 





















































The ROC curves of RF and SVM classifiers for predicting brain-specific genes 
and live-specific genes have been compared in Figure 2.2. The ROC curves of RF and 
SVM classifiers are not significantly different for the prediction of liver-specific genes 
(Figure 2.2b). However, The ROC curve of RF classifier was clearly better than the SVM 
classifier for the prediction of brain-specific genes (Figure 2.2a). The results confirm that 
RF classifier outperforms the SVM models for tissue- p cific gene prediction. The 
possible reason is that RFs can handle a large number of input variables and avoid model 
overfitting. The use of 2,968 expression profiles for input vector encoding results in the 
same large number of input variables, which may lead to model overfitting. Interestingly, 
the RF algorithm can handle the situation and show better predictive performance in the 




Figure 2.3 ROC curves to compare the performances of Random Forest (RF) and Support 
Vector Machine (SVM) classifiers for predicting tissue-specific genes. 
 
Brain-specific gene expression 
The human brain gives us the ability to think and sets us apart from other animals. 
It has a highly complex structure which contains different regions with specific functions. 
For example, the hippocampus is involved in spatial navigation and long-term memories, 
whereas the cerebral cortex plays key roles in langu ge, attention and consciousness. Any 
damage in these regions results in various mental disorders including Alzheimer disease, 
Parkinson's disease and Mood disorder. In this study, the predicted brain-specific genes 
are expected to have preferential expression in the brain, and may play important roles in 
neuron functions such as synaptic transmission and neuronal migration.  
In the study, 1,408 candidate targets with positive scores (the average value of 
classifier outputs from ten predictions) were predicted as the brain-specific genes 
(Additional file B1). In Figure 2.4, the expression patterns of candidate gene targets using 
RF classifier are visualized with the heat maps generated using TM4 MeV. The predicted 
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targets show clear expression patterns in brain samples, which indicates that our approach 
is useful for brain-specific gene prediction. Similar to the known brain-specific genes, the 
transcripts of the predicted targets are also detected in retina samples. GO enrichment 
analysis of the candidate targets demonstrates that many candidate genes have basic 
neuron functions (Table 2.2).  For example, neurotransmission is an electrical or 
chemical signal motion within synapses caused by transmission of a nerve impulse. The 
predictions are enriched for neurotransmission-related GO terms such as “synapse”, 
“synapse part”, “transmission of nerve impulse”, “neuron projection”, “synaptic 
transmission” and “passive transmembrane transporter activity”. Some channel-related 
GO terms including “ion channel activity”, “substrate specific channel activity”, “gated 
channel activity” and “channel activity” are detected in the enrichment analysis of our 
predictions. 
 
Table 2.2 GO term enrichment analysis of predicted brain-specific genes.  
*Count: the number of genes involved in the given GO term; %: the percentage of 
involved genes in total genes; P-Value: the modifie Fisher Exact P-Value. 
Category Term Count* %* P-Value* 
GOTERM_CC_FAT GO:0045202~synapse 103 11.41 .37E-49 
GOTERM_CC_FAT GO:0044456~synapse part 83 9.19 2.68E-45 
GOTERM_BP_FAT 
GO:0019226~transmission of nerve 
impulse 
80 8.86 5.25E-36 
GOTERM_CC_FAT GO:0043005~neuron projection 85 9.41 4.00E-35 
GOTERM_BP_FAT GO:0007268~synaptic transmission 73 8.08 6.82E-35 




77 8.53 3.03E-30 
GOTERM_MF_FAT GO:0022836~gated channel activity 68 7.53 4.80E-30 




77 8.53 3.87E-29 
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Figure 2.4 Visualization of predicted tissue-specific gene expression patterns. 
 
Table 2.3 shows the top 20 high-scoring predictions from RF classifiers. The 
predicted targets were not shown to have brain-specific xpression from the annotations 
of UniProt, thus the genes are excluded from the training datasets. However, recent 
studies suggest that some predicted targets, includi g BRUNOL4, ANKS1B, TRIM9, 
NCAN, FAIM2, OPCML and FXYD7, are expressed predominantly in the brain. For 
example, the RNA-binding protein encoded by BRUNOL4 plays an important role in 
many cellular processes including RNA stability, pre-mRNA alternative splicing, mRNA 
editing and translation [15, 16]. It was shown that the protein was predominantly 
expressed in the brain with enrichment in the hippocampus [17]. In this study, the probes 
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of BRUNOL4 have the highest (223654_s_at, 0.8753) and fourth-ranked (238966_at, 
0.8600) scores. ANKS1B encodes an Amyloid-beta protein which can regulate th  
nucleoplasmic coilin protein interactions in neuronal cells. Previous studies showed that 
the protein was mainly expressed in brain and may be implicated in Alzheimer’s disease 
[18]. Brain-specific E3 ligase encoded by TRIM9 has a high level of expression in the 
cerebral cortex and may be involved in the pathogenesis of Parkinson's disease [19]. 
Neurocan (NCAN) modulates neuronal adhesion and migration and is expressed 
preferentially in the brain [20]. The protein encoded by FAIM2 could protect cells from 
Fas-mediated apoptosis and shows a high level of expression in the hippocampus [21]. It 
was shown that OPCML was predominantly expressed in cerebellum and cerebral cortex 
[22], whereas FXYD7 was preferentially expressed in the brain [23]. 
Other predicted targets have not been previously suggested to have brain-specific 
expression, but some candidate genes, including GNAO1, SV2A, SYN2, UNC13A and 
NTRK2, are involved in basic neuron functions (Table 2.3). Guanine nucleotide binding 
protein (GNAO1)  mediates the physiological effects of various neuronal receptors [24]. 
SV2A, SYN2 and UNC13A encode proteins which are important for synaptic transmission 
in the central and peripheral nervous system [25, 26]. NTRK2 encodes a neurotrophic 
tyrosine kinase receptor for brain-derived neurotrophic factor (BDNF) and is implicated 
in childhood mood disorder [27]. By contrast, the functions of some high scoring genes in 
brain remain to be characterized. HS6ST3 encodes a Heparan sulphate sulfotransferase 
which plays a key role in the modulation of fibroblast growth factor signalling [28]. The 
protein encoded by SCN2A forms a voltage-dependent sodium channel and is associ ted 
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with generalized epilepsy with febrile seizures plus [29]. The corresponding genes of 
three cDNA sequences (LOC389073, AA879409, AI186173) were not determined, and 
their functions in the brain are not clear. The results suggest that the machine learning 
approach developed in the present study can be used to identify some interesting targets 
for further experimental studies. 
 
Table 2.3 List of high-scoring genes with specific expression in the brain. 
Probe Gene Description Score* 
223654_s_at BRUNOL4 Bruno-like 4, RNA binding protein (Drosophila) 0.8753 
227440_at ANKS1B 
Ankyrin repeat and sterile alpha motif domain 
containing 1B 
0.8685 
230280_at TRIM9 Tripartite motif-containing 9 0.866 
238966_at BRUNOL4 Bruno-like 4, RNA binding protein (Drosophila) 0.8345 
205143_at NCAN Neurocan 0.832 
204762_s_at GNAO1 
Guanine nucleotide binding protein (G protein), 
alpha activating activity polypeptide O 
0.8201 
232276_at HS6ST3 Heparan sulfate 6-O-sulfotransferae 3 0.8186 
203619_s_at FAIM2 Fas apoptotic inhibitory molecule 2 0.8124 
241998_at LOC389073 Similar to RIKEN cDNA D630023F18 0.8074 
206381_at SCN2A Sodium channel, voltage-gated, type II, alpha subunit 0.8021 
203069_at SV2A Synaptic vesicle glycoprotein 2A 0.7998 
1557256_a_at AA879409 CDNA FLJ37672 fis, clone BRHIP2012059 0.797 
229039_at SYN2 Synapsin II 0.7956 
242651_at AI186173 Transcribed locus 0.7951 
227453_at UNC13A unc-13 homolog A (C. elegans) 0.7888 
203618_at FAIM2 Fas apoptotic inhibitory molecule 2 0.7744 
229463_at NTRK2 Neurotrophic tyrosine kinase, receptor, type 2 0.7728 
214111_at OPCML Opioid binding protein/cell adhesion molecule-like 0.7722 
214376_at AI263044 Clone 24626 mRNA sequence  0.7668 
220131_at FXYD7 FXYD domain containing ion transport regulator 7 0.7662 
* Score: the average value of RF classifier outputs from ten predictions. 
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Liver-specific gene expression 
The liver is a vital organ for human metabolism, and plays key roles in detoxification, 
plasma protein synthesis, glycogen storage and hormone production. For example, liver is 
the source and target organ of inflammatory mediators in the pathogenesis of 
inflammatory response syndrome [30], and it is respon ible for the production of 
coagulation factors. Thus, the liver-specific targets identified in this study might be 
involved in basic liver functions. We identified 493 liver-specific gene targets with 
positive scores in the analysis (Additional file B2). The functional analysis of the liver-
specific gene targets using RF classifier confirms that many of the predicted targets are 
enriched for liver-related GO terms (Table 2.4). For example, the GO terms for 
inflammatory response contained “acute inflammatory response”, “response to 
wounding” and “activation of plasma proteins involved in acute inflammatory response”; 
the coagulation-related GO terms included “blood coagulation”, “coagulation” and 
“hemostasis”. The expression patterns of the predict  liver-specific genes are visualized 
with the heat map (Figure 2.3). Clearly, the transcripts of the predicted targets are 














Table 2.4 GO term enrichment analysis of predicted liver-specific genes.  
*Count: the number of genes involved in the given GO term; %: the percentage of 
involved genes in total genes; P-Value: the modifie Fisher Exact P-Value. 
 
As listed in Table 2.5, 17 of the top 20 high-scoring genes are involved in the 
metabolism of human liver. The genes include F11, F9, SERPINC1, APOA2, AKR1D1, 
ACSM2, ITIH2, PON1, CPB2, AFM, NR0B2, ALB, CYP4A11, PGLYRP2 and SLC22A7. 
For example, F11, F9 and SERPINC1 are involved in the regulation of blood coagulation 
cascade [31]. APOA2 encodes apolipoprotein which is synthesized mainly i  liver and 
involved in the metabolism of high density lipoprotein [32]. AKR1D1 encodes the aldo-
keto reductase catalyzing the reduction of steroid hormones [33],  whereas ACSM2 
encodes enzyme catalyzing the activation of medium-chain length fatty acids [34].  The 
genes were not shown to have liver-specific expression in UniProt annotations, but recent 
studies suggest that the genes are expressed preferentially in the liver. The expression and 
functions of other three predictions (BG398937, C6 and LPA) have not been well 
documented in the literature. 




29 8.41 1.65E-24 
GOTERM_BP_FAT GO:0009611~response to wounding 55 15.94 8.55E-23 
GOTERM_CC_FAT GO:0005615~extracellular space 63 18.26 8.65E-23 
GOTERM_CC_FAT GO:0005576~extracellular region 109 31.59 1.35E-21 
GOTERM_BP_FAT GO:0007596~blood coagulation 25 7.25 5.55E-19 
GOTERM_BP_FAT GO:0050817~coagulation 25 7.25 5.55E-19 
GOTERM_BP_FAT GO:0007599~hemostasis 25 7.25 2.33E-18 
GOTERM_BP_FAT GO:0055114~oxidation reduction 54 15.65 2.46E-18 
GOTERM_BP_FAT GO:0006956~complement activation 18 5.22 2.70E-18 
GOTERM_BP_FAT 
GO:0002541~activation of plasma 
proteins involved in acute 
inflammatory response 
18 5.22 4.37E-18 
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Table 2.5 List of high-scoring genes with specific expression in the liver. 
Probe Gene Description Score* 
206610_s_at F11 
Coagulation factor XI (plasma thromboplastin 
antecedent) 
0.7869 
1554491_a_at SERPINC1 Serpin peptidase inhibitor, clade C member 1 0.7737 
219465_at APOA2 Apolipoprotein A-II 0.7609 
217512_at BG398937 Unknown 0.7559 
207102_at AKR1D1 Aldo-keto reductase family 1, membr D1  0.7466 
207218_at F9 Coagulation factor IX  0.725 
210168_at C6 Complement component 6 0.7239 
204987_at ITIH2 Inter-alpha (globulin) inhibitor H2 0.7191 
209978_s_at LPA/PLG Lipoprotein, Lp(a) / plasminogen 0.7191 
214069_at ACSM2 Acyl-CoA synthetase medium-chain family member 2 0.7099 
206345_s_at PON1 Paraoxonase 1 0.7004 
206651_s_at CPB2 Carboxypeptidase B2 (plasma) 0.6959 
241914_s_at ACSM2 Acyl-CoA synthetase medium-chain family member 2 0.6945 
206840_at AFM Afamin 0.6846 
206410_at NR0B2 Nuclear receptor subfamily 0, group B, member 2 0.6837 
214842_s_at ALB Albumin 0.6809 
217319_x_at CYP4A11 
Cytochrome P450, family 4,subfamily A, polypeptide 
11 
0.6772 
242817_at PGLYRP2 Peptidoglycan recognition protein 2 0.6765 
207407_x_at CYP4A11 
Cytochrome P450, family 4, subfamily A, polypeptide 
11 
0.6752 
231398_at SLC22A7 Solute carrier family 22, member 7 0.6746 
* Score: the average value of RF classifier outputs from ten predictions. 
 
Tissue-selective gene prediction 
Tissue-specific genes are considered as the special case of tissue-selective genes. 
Our approach was developed for tissue-specific gene predictions, but its application to 
tissue-selective gene predictions is straightforward. In this study, the RF classifiers were 
used to predict the genes that are expressed preferentially in the brain, liver, testis, blood 
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and kidney. As shown in Table 2.6, The RF classifier  reached high predictive 
performance for tissue-selective gene prediction.  For example, the classifier for brain-
selective gene prediction shows overall accuracy (AC) at 92.70% with Matthews 
Correlation Coefficient (MCC) = 0.4925.  The classifier for liver-selective gene 
prediction gave predictive performance with the overall accuracy at 96.02% and MCC = 
0.7378. It is noteworthy that the classifiers used for tissue-specific gene prediction 
achieved higher predictive performance than those fr tissue-selective gene prediction. 
For instance, the AUC value of RF classifier for brain-specific gene prediction (AUC = 
0.9488, Table 2.1) is higher than that for brain-selective gene prediction (AUC = 0.9178, 
Table 2.6), whereas the RF classifier gave better predictive performance for liver-specific 
gene prediction (AUC = 0.9777, Table 2.1) than liver-s lective gene prediction (AUC = 
0.9547, Table 2.6). The possible explanation is that t e tissue-specific genes are 
expressed specifically in only one particular tissue type, thus the clear expression patterns 
of the genes may improve the quality of classifiers and result in high predictive 
performance for predictions. 
The RF classifiers gave high predictive performance for predicting genes that 
have preferential expression in other tissue types. The testis is the male sex gland, which 
produces sperm, male reproductive cell and sex hormones. The classifier for testis-
selective gene prediction reached predictive performance with overall accuracy at 
91.00% and ROC AUC = 0.8433. The blood transports oxygen and nutrients to other 
tissues and carries away waste products from cells. The classifier for blood-selective gene 
prediction showed overall accuracy at 93.29% with MCC = 0.5109 and ROC AUC = 
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0.9170. The kidneys play key roles in urinary system.  The organs filter waste products 
from the blood and excrete them in urine. The classifier for kidney-selective gene 
prediction achieved predictive performance with overall accuracy at 93.62% with MCC = 
0.4648 and ROC AUC = 0.9300. The results suggest that our approach can be used to 
identify the genes that have preferential expression in different types of tissues. 
 
 
Table 2.6 Random Forest classifiers for predicting tissue-selective genes. The values 
outside and inside brackets are the average value and st ndard deviation of measures in 
ten classifier evaluations, respectively. 
 
CONCLUSION 
A machine learning approach has been developed in this s udy for identifying the 
human tissue/specific gene targets. Random Forests (RF ) and Support Vector Machines 
(SVMs) were trained separately with the microarray gene expression data to construct 
classifiers for prediction. It was shown that the RF classifiers outperform SVM models 
for tissue-specific gene prediction. 1,408 brain-specific gene targets and 493 liver-





























































clear expression patterns in corresponding tissue samples and have functions consistent 
with the tissues in GO enrichment analysis. The analysis of high-scoring candidate genes 
for brain and liver specific expression suggests that our approach can select some 
interesting targets for further experimental studies. Our approach could also provide 
useful information for tissue-selective gene prediction. The approach can be used to 
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PREDICTING PROTEIN SUMOYLATION SITES FROM SEQUENCE FEATURES2 
 
ABSTRACT 
Protein sumoylation is a post-translational modification that plays an important 
role in a wide range of cellular processes. Small ubiq itin-related modifier (SUMO) can 
be covalently and reversibly conjugated to the sumoylati n sites of target proteins, many 
of which are implicated in various human genetic disorders. The accurate prediction of 
protein sumoylation sites may help biomedical researchers to design their experiments 
and understand the molecular mechanism of protein sumoylation. In this study, a new 
machine learning approach has been developed for predicting sumoylation sites from 
protein sequence information. Random Forests (RFs) and Support Vector Machines 
(SVMs) were trained with the data collected from the literature. Domain-specific 
knowledge in terms of relevant biological features was used for input vector encoding. It 
was shown that RF classifier performance was affected by the sequence context of 
sumoylation sites, and twenty residues with the cor motif ΨKXE in the middle appeared 
to provide enough context information for sumoylation site prediction. The RF classifiers 
were also found to outperform SVM models for predicting protein sumoylation sites from 
sequence features. The results suggest that the machine learning approach gives rise to 
more accurate prediction of protein sumoylation sites than previous studies. The RF and 
SVM models were used to develop a new web server, called seeSUMO (freely available 
                                                  
2Teng S, Luo H, Wang L: Predicting protein sumoylation sites from sequence features, submitted. 
 40




Post-translational modifications regulate protein functions, and orchestrate a 
variety of cellular processes. Protein sumoylation, an important reversible post-
translational modification, is essential for many eukaryotic cellular processes, including 
DNA damage recovery regulation, subcellular transport, transcription factor 
transactivation, protein stability, cell cycle progession and chromosome segregation [1]. 
Small ubiquitin-related modifier (SUMO) can be covalently attached to and detached 
from specific lysine residues in target proteins [2]. Many sumoylated proteins, including 
huntingtin, DJ-1, ataxin-1 and tau, play key roles in disease states. For instance, the 
stability and correct targeting of huntingtin are controlled by sumoylation, and any 
alternations of the process may cause Huntington's disease [3]. Sumoylation is also 
involved in the pathogenesis of Parkinson's disease, Alzheimer's disease, neuronal 
intranuclear inclusion disease, amyotrophic lateral sc erosis, spinobulbar muscular 
atrophy, spinocerebellar ataxia type 1 and several human cancers [4]. 
Only one or a few lysine residues in a protein may be involved in sumoylation.  It 
is rather difficult and time-consuming to identify the sumoylated lysine among many 
candidate lysine residues through experimental approaches. Accurate computational 
prediction of protein sumoylation sites can help biologists better design their experiments 
and interpret the experimental data. A core consensus motif ΨKXE has been identified 
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for sumoylation sites, in which Ψ represents an aliphatic amino acid (I, V, L, A, P or M), 
K is the sumoylation site, X indicates any amino acid, and E is glutamic acid. Extended 
sumoylation motifs have also been reported [5], such as NDSM (negatively charged 
amino acid-dependent sumoylation motif: ΨKXE + downstream cluster of [D/E]) [6], 
PDSM (phosphorylation-dependent sumoylation motif: ΨKXEXXSP) [7] and SUMO-
acetyl switch (ΨKXEP) [8]. These findings suggest that the sequence flanking the core 
motif (ΨKXE) may also contribute to the specific recognition f the sumoylation sites. 
Moreover, it is noteworthy that some sumoylation sites do not follow the above motifs, 
and not all lysine residues matched to these motifs are sumoylated. It is still challenging 
to accurately predict the true sumoylation sites recognized by the cellular machinery. 
Accurate prediction of sumoylation site could help understand the mechanism of 
protein sumoylation underlying human genetic disorders. Several computational methods 
have been reported for predicting sumoylation sites. A statistical method used by the 
SUMOpre web server [9] can predict sumoylation sites at the overall accuracy of 96.71% 
and Matthews Correlation Coefficient of 0.6364 in cross-validation tests. Xue et al. [10] 
developed the SUMOsp 1.0 web server, which used the Group-based Phosphorylation 
Scoring (GPS) algorithm with the pattern recognitio strategy MotifX for sumoylation 
site prediction. SUMOsp 2.0 [11] was developed with the upgraded GPS algorithm. It has 
been shown that SUMOsp 2.0 reached better predictive performance than SUMOsp 1.0. 
However, the previous studies did not utilize the domain-specific knowledge for classifier 
construction. 
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Domain-specific knowledge in terms of relevant biological features can be used to 
enhance classifier performance for predicting DNA-binding residues and protein stability 
changes upon amino acid substitutions [12-14]. For example, the predictive performance 
of  DNA-binding site prediction could be significantly improved by using biochemical 
features [14] and evolutionary information [15] for input vector encoding. In this study, 
we have developed a new approach for sequence-based prediction of protein sumoylation 
sites using Random Forests (RFs) and Support Vector Machines (SVMs). The biological 
knowledge in terms of forty sequence features were used for input encoding. It was found 
that the RF classifier performance was affected by sequence context of sumoylation sites. 
The results obtained in this study indicate that the RF classifiers achieved better 
predictive performance than the SVM classifiers andprevious predictors. To make our 
classifiers publicly accessible to the biological research community, we have developed a 




We collected 457 experimentally verified sumoylation sites in 263 proteins, by 
searching the research articles in NCBI PubMed using ‘SUMO’ and ‘sumoylation’ as 
keywords (Appendix C, Table C.1). This dataset contained all the instances used by 
SUMOpre [9], including 268 sumoylation sites in 159 proteins from research articles 
reported before August 10, 2006. The other 189 sumoylati n sites have been manually 
collected from research articles published between August 10, 2006 and June 1, 2010. 
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The amino acid sequences of these proteins were extacted from the SwissProt database. 
In order to remove redundancy in the dataset, the blastclust program in the BLAST 
software package (http://blast.ncbi.nlm.nih.gov/) was used for clustering analysis with a 
25% sequence identity threshold, and ClustalX [16] was used for multiple sequence 
alignment of the sequences in each cluster. The redundant sumoylation sites were 
manually removed from the dataset. The final dataset contains 9,952 lysine residues in 
247 proteins, including 425 non-redundant sumoylation sites used as positive data 
instances and 9,527 non-sumoylated lysine sites used a  negative data instances. 
To compare the predictive performance of our classifier  with previous predictors, 
the final dataset was divided into two subsets.  The training dataset included 377 
sumoylation sites and 8,237 non-sumoylated lysine residues in 221 proteins from 
publications before January 2010. The remaining 48 sumoylation sites and 1,290 non-
sumoylation sites in 26 proteins reported after January 2010 were used as the test dataset 
for classifier evaluation and comparison. 
 
Sequence logos 
Protein Sequence Logos (http://www.cbs.dtu.dk/~gorodkin/appl/plogo.html) was 
used to generate the sequence logo for visualizing the sequence pattern of sumoylation 
motifs. The twenty eight residues with the core motif ΨKXE in the middle of 388 known 
sumoylation sites was used as the inputs, and the frequencies of residues at each position 
were measured in bits of information as described in previous studies [17, 18].  The 
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height of residue k at position i (dik) is proportional to its frequency relative to the 









        (3.1) 
where qik represents the fraction of residue k at position i, and pk indicates the priori 
amino acid distribution, which was set to the amino acid composition obtained from 
UniProtKB/Swiss-Prot Release 57.15 in this study. I i is the information content of 










== 2log       (3.2) 
where A is the set of residues including gaps. 
 
Sequence features 
Forty biological features, including ten biochemical features, seven structural 
features, nine thermodynamic features, six empirical fe tures and eight other biological 
features, selected from Protscale [19] and AAindex [20], were used to encode each amino 
acid residue in a data instance (Appendix C, Table C.2). These features represent 
different types of biological knowledge such as biochemical properties, structural 
information, protein stability, folding energy, etc. For example, the biochemical feature, 
polarity (P), represents the dipole-dipole intermolecular interactions between the 
positively and negatively charged residues, and the structural feature, conformational 
parameter for alpha-helix (A), indicates the tendency of an amino acid to form the 
secondary structures, alpha-helix. Some of these featur s were used for predicting DNA-
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It was shown that utilizing the evolutionary information in terms of position-
specific scoring matrix (PSSM) scores could improve th  performance of Random 
Forests for DNA-binding site prediction [21].  The PSSM scores generated by PSI-
BLAST in this study indicated how well each position f a sequence was conserved 
among its homologues. The protein sequences downloaded from UniProtKB/Swiss-Prot 
(http://www.pir.uniprot.org/, release 57.15) were used as the reference database, and PSI-
BLAST was run for three iterations with the E-value threshold set to 1e-5. 
 
Random Forests 
The use of forty biological features and evolutionary information for input vector 
encoding gives rise to a large number of input variables, especially with a large window 
size. Considering the relatively small number of positive instances (experimentally 
identified sumoylation sites) available for this study, this might result in model 
overfitting. To avoid model overfitting, the Random Forest (RF) learning algorithm was 
used in this study.  A typical RF model is made up of many independent decision trees 
constructed using bootstrap samples from the training data. During tree construction, m 
variables out of all the n input variables (m << n) are randomly selected at each node, and 
the tree nodes are split using the selected m variables. For classifying a data instance, a 
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RF classifier combines the votes made by the decision trees, and gives the most popular 
class as the output of the ensemble. Because of the random feature selection, RFs have 
the capability of handling a large number of input variables and avoid model overfitting.  
In this study, the RF algorithm is implemented using the randomForest package in 
R. The number of variables selected to split each node (mtry) was set to 6, and the 
number of trees to grow (ntree) was set to 1000. Other values of the mtry and ntree 
parameters for training were also examined, but did not result in significant improvement 
of classifier performance. 
 
Support vector machine training 
Support Vector Machine (SVM) classifiers were also constructed, and compared 
with RF classifiers for protein sumoylation site prediction. The SVM method is a data-
driven approach for binary classification. The SVM learning algorithm can be described 
by four basic concepts, including the separating hyperplane, the maximum-margin 
hyperplane, the soft margin, and the kernel functio [22]. For a linear classification, data 
instances are represented as n-dimensional vectors, and an (n – 1) dimensional 
hyperplane is used to separate the positive instances from the negative ones. Non-linear 
classifications are generally used for the analysis of complex biological data. In these 
cases, a kernel function can be used to measure the distance between data points in a 
higher dimensional space, which allows the SVM algorithm to fit the maximum-margin 
hyperplane in the transformed space. The SVMlight software package 
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(http://svmlight.joachims.org/) was utilized to construct the SVM classifiers using the 
radial basis function (RBF) kernel in this study. 
In this study, forty biological features were used to build the SVM models. 
However, the features used for classifier construction might contain redundant or 
correlated information. Thus, feature selection was performed to choose an optional 
subset of relevant features for constructing simple, efficient models. The five relevant 
features were selected by Random Forests, and then used to construct SVM classifiers. 
 
Classifier evaluation 
The predictive performance of classifier was evaluated by tenfold cross-
validation. The whole dataset were randomly distribu ed into ten folds. In each of the ten 
iterations, the classifier was trained in nine of the en folds and tested in the remaining 
one fold. Since the dataset was imbalanced with only 4% of lysine residues as 
sumoylation sites, the positive instances of training data were replicated to get the 
approximately equal number with the negative instances. However, the positive instances 
in the test data were not replicated. The prediction results made for the test data instances 
in all the ten iterations were combined and evaluated by various performance measures, 
including Accuracy (AC), Sensitivity (SN), Specificty (SP), Strength (ST) and Matthews 































=  (3.7) 
where TP is the number of true positives; TN is the number of true negatives; FP is the 
number of false positives; and FN is the number of false negatives. For imbalanced 
datasets, the accuracy alone could be misleading. Thus, sensitivity, specificity and their 
average (strength) were also computed from prediction results. MCC was used to 
measure the correlation between predictions and the actual class labels. However, 
different trade-offs of sensitivity and specificity may give rise to different MCC values 
for a classifier.  
The Receiver Operating Characteristic (ROC) curve [23] is probably the most 
robust approach for classifier evaluation and comparison. In the present study, the ROC 
curve was generated by varying the output threshold of a RF classifier and plotting the 
true positive rate (sensitivity) against the false positive rate (1 – specificity) for each 
threshold value. Since the ROC curve of an accurate cl ssifier is close to the left-hand 
and top borders of the plot, the area under the curve (AUC) can be used as a reliable 
measure of classifier performance [24]. The range of AUC value is 0.5 (random 





RESULTS AND DISCUSSION 
Sequence patterns of protein sumoylation sites 
Protein sumoylation sites are often identified with the consensus motif ΨKXE, 
where Ψ represents an aliphatic amino acid (I, V, L, A, P or M), and X indicates any 
residue. However, 159 (~35%) of 457 known sumoylation sites in this study do not 
contain the core motif (ΨKXE), whereas the dataset contains 228 non-sumoylated lysine 
residues that match this motif. To visualize the sequence patterns in sumoylation sites and 
their flanking sequences, the sequence logo was generated using the 28-residue sequences 
from 388 experimentally identified sumoylation site (Figure 3.1). The result suggests 
that certain positions outside of the core motif (ΨKXE), such as the positions -7, 1, 3, 4 
and 9, may contain some information for the specific recognition of sumoylation sites in 
the cell. For instance, the most abundant residue at positions 1 is Proline (P), which 
agrees well with the SUMO-acetyl switch (ΨKXEP). Interestingly, glutamine (Q), 
Methionine (M) and Threonine (T) appear to be more abundant than any other residues in 
the X position of the core motif ΨKXE, suggesting that there may be subtle amino acid
preference at the X position. 
The above observations suggest that the flanking sequences of protein 
sumoylation sites have some subtle patterns. However, th se patterns may not be 
modelled completely by consensus motifs or sequence logos, which do not consider the 
dependence among neighboring residues. Thus, a machine learning approach has been 




Figure 3.1 The sequence logo of the protein sumoylati n motif (ΨKXE) and its flanking 
residues. 
 
Effect of sequence context on classifier performance 
We first constructed Random Forest (RF) classifiers using the forty biological 
features for input vector encoding. The RF classifiers were trained with data instances of 
various window sizes. The results suggest that RF classifier performance was affected by 
the sequence context of sumoylation sites (Table 3.1). The classifier constructed with KX 
(window size w = 2) gave predictive performance with the prediction strength (ST) = 
57.07%, Matthews Correlation Coefficient (MCC) = 0.0590 and ROC AUC = 0.6107. 
The classifier performance was improved significantly when the core motif ΨKXE (w = 
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4) was used for input encoding. The classifier gave the prediction strength at 82.04% with 
MCC = 0.5379 and AUC = 0.9024. When the neighboring esidues of the core motif 
were used to construct the classifiers, the predictive performance was further improved. 
For example, the classifier constructed with ΨKXE+/-5 (w = 14) achieved the highest 
MCC at 0.6786. Since the dataset was imbalanced with only 4% of lysine residues as the 
sumoylation sites, the ROC AUC is probably the most reliable performance measure for 
the present study. The classifier using the twenty residues with the core motif ΨKXE in 
the middle (ΨKXE+/-8, w = 20) reached the highest ROC AUC at 0.9200. The classifier 
also shows the highest overall accuracy at 97.68% with 56.00% sensitivity and 99.50% 
specificity, and high MCC = 0.6711. Thus, this RF classifier is considered as the best 
classifier in Table 3.1.  
 
Table 3.1 Effect of sequence context on predictive performance of Random Forest 
classifiers. 










KX 61.80 51.89 62.25 57.07 0.0590 0.6107 
ΨKXE 95.27 67.57 96.52 82.04 0.5379 0.9024 
ΨKXE+/-1 97.28 61.35 98.90 80.13 0.6489 0.9038 
ΨKXE+/-2 97.42 59.73 99.12 79.42 0.6582 0.9145 
ΨKXE+/-3 97.45 60.00 99.15 79.58 0.6638 0.9172 
ΨKXE+/-4 97.54 60.28 99.20 79.74 0.6688 0.9074 
ΨKXE+/-5 97.63 60.00 99.31 79.65 0.6786 0.9103 
ΨKXE+/-6 97.57 57.78 99.34 78.56 0.6668 0.9048 
ΨKXE+/-7 97.54 54.86 99.40 77.13 0.6508 0.9188 
ΨKXE+/-8 97.68 56.00 99.50 77.75 0.6711 0.9200 
ΨKXE+/-9 97.59 51.71 99.60 75.66 0.6522 0.9133 
ΨKXE+/-10 97.57 47.65 99.70 73.67 0.6340 0.9149 
ΨKXE+/-11 97.46 43.82 99.75 71.79 0.6115 0.9136 
ΨKXE+/-12 97.43 42.35 99.79 71.07 0.6056 0.9124 
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The ROC analysis for investigating the effect of sequence context information on 
RF classifier performance has been shown in Figure 3.2. The classifier constructed with 
ΨKXE is clearly better than the classifier constructed with KX. Furthermore, the 
classifier using twenty residues with the core motif in the middle (ΨKXE+/-8) appears to 
be slightly better than the classifier constructed with ΨKXE. The results suggest that the 








RF versus SVM classifiers 
Support Vector Machines (SVMs) have been widely used for biological pattern 
classification. In this study, we constructed SVM classifiers using the forty biological 
features, and compared their ROC AUC values with those of the RF classifiers over 
various window sizes. As shown in Figure 3.3, the RF classifiers using the forty features 
(RF40) achieved comparable performance measures over various window sizes with the 
highest AUC at w = 20 (ΨKXE+/-8). However, SVM classifiers using the forty features 
(SVM40) showed significantly degraded performances with large window sizes. For 
example, the AUC value of SVM40 decreased from 0.8090 to 0.5254 when the window 
size was increased from w = 4 (ΨKXE) to w = 8 (ΨKXE+/-2). Thus, the SVM classifiers 
did not achieve the same level of predictive performance as the RF classifiers. The 
possible explanation is that some of the forty features may contain redundant or 
correlated information for sumoylation site prediction, which may have caused the 
degradation of SVM classifier performance.  
To enhance the predictive performance of SVM classifier , feature selection was 
performed using Random Forests (RFs).  Five highly relevant features selected by RFs, 
including polarity (P), conformational parameters for alpha helix (A) and coil (C), short 
and medium range non-bonded energy per residue (Er) and free energy in alpha-helical 
conformation (Ea), were used to construct the SVM classifiers (SVM5). As shown in 
Figure 3.3, the ROC AUC values of the SVM5 classifiers were higher than those of the 
SVM40 classifiers over various window sizes. For example, the SVM5 classifier 
constructed using eight residues (ΨKXE+/-2, w = 8) achieved the highest AUC value of 
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0.8917 over various window sizes (Figure 3.3), which was significantly higher than the 
AUC value of the SVM40 classifier (AUC = 0.5254 at w = 8). This classifier reached the 
prediction strength at 78.42% (58.38% sensitivity and 98.46% specificity) and MCC = 
0.5902 (Table 3.2). The SVM5 classifier constructed with ΨKXE+/-2 was regarded as the 
best SVM classifier in this study. 
 
 
Figure 3.3 Performance comparisons of Random Forest (RF) and Support Vector 
Machine (SVM) classifiers. 
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However, the RF40 classifiers still outperformed the SVM5 models (Figure 3.3). 
As shown in Table 3.2, The RF40 classifier constructed using eight residues (ΨKXE+/-2) 
achieved the prediction strength of 79.42% with MCC = 0.6582 and AUC = 0.9145, 
which were higher than those of the SVM5 classifier n the same window size. Thus, the 
RF algorithm appears to be better for predicting protein sumoylation sites from sequence 
features. The possible explanation is that RFs can h dle a large number of input 
variables and avoid model overfitting. The feature-encoded input vector has a large 
number of variables, especially with a large window size. For example, when twenty 
residues (w = 20) are used for classifier construction, the number of input variables is 800 
for classifiers using forty features and 100 for classifiers using five features. The large 
number of input variables, together with the small number of positive instances, may lead 
to model overfitting. 
 
Table 3.2 Comparison of Random Forest and Support Vector Machine classifiers 
constructed with ΨKXE+/-2 (w = 8). 









RF40 97.42 59.73 99.12 79.42 0.6582 0.9145 
SVM5 96.73 58.38 98.46 78.42 0.5902 0.8917 
SVM40 95.66 0.00 99.99 49.99 -0.0023 0.5254 
 
Use of evolutionary information 
Evolutionary information in terms of position-specific scoring matrix (PSSM) 
scores was previously shown to improve classifier pformance [21, 25, 26]. To 
determine whether or not sumoylation site prediction c uld be further improved by using 
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evolutionary information, the PSSM scores of twenty residues with the core motif ΨKXE 
in the middle were used to construct the RF classifier . The scores in a PSSM represent 
how well each position of a protein sequence was conserved among its homologues. As 
shown in Table 3.3, the RF classifier constructed with PSSMs (PSSM, Table 3.3) reached 
the prediction strength of 51.96% with MCC = 0.1566 and AUC = 0.8672. By using both 
PSSMs and the forty biological features for input vector encoding, the RF classifier (Bio 
+ PSSM, Table 3.3) gave a relatively high classifier p rformance (74.82% prediction 
strength, MCC = 0.6443 and AUC = 0.9181). However, these performance measures 
were not significantly different from those of the RF classifier using the biological 
features only (Bio, Table 3.3). 
 
Table 3.3 Effect of evolutionary information on protein sumoylation site prediction. 









PSSM 95.90 4.00 99.91 51.96 0.1566 0.8672 
Bio 97.68 56.00 99.50 77.75 0.6711 0.9200 
Bio + PSSM 97.56 50.00 99.64 74.82 0.6443 0.9181 
 
The ROC curves of the three RF classifiers are compared in Figure 3.4. The 
results confirm that classifier performance is not improved by adding the evolutionary 
information to the biological features for input encoding. The possible explanation is that 
the PSSM, which is designed for PSI-BLAST searches, may not capture the evolutionary 
information for sumoylation site prediction. Another possibility is that the forty 
biological features may already contain the evolutinary information necessary for 
predicting protein sumoylation sites. 
 57
 
Figure 3.4 ROC curves to show the effect of evolutinary information on classifier 
performance. 
 
Comparison with previous studies 
The existing computational methods for protein sumoylation site prediction 
include SUMOplot (http://www.abgent.com//tools/toSumoplot), SUMOsp2 
(http://sumosp.biocuckoo.org/online.php) and SUMOpre [9]. The datasets used in these 
previous studies are smaller than the dataset used in the present work. We manually 
collected additional instances of experimentally identified sumoylation sites from the 
latest publications. To further demonstrate the improved performance of our classifiers, 
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the most accurate RF classifier (ΨKXE+/-8, Table 3.1) and SVM classifier (SVM5, Table 
3.2) have been compared with the previous classifier , SUMOplot and SUMOsp2, using 
an independent test dataset with 48 sumoylation sites reported after January 2010. 
SUMOplot predicts the probability of sumoylation site  based on the SUMO consensus 
sequence and hydrophobicity, whereas SUMOsp2 [11] uses two pattern recognition 
strategies (GPS and MotifX) for sumoylation site prdiction. The two types of prediction 
in SUMOplot were low (motifs with low probability) and high (motifs with high 
probability), whereas the three levels of stringency in SUMOsp2 were low, medium and 
high. The corresponding thresholds of classifier output in our approach (seeSUMO) were 
set to -0.2 (low), 0 (medium) and 0.2 (high). 
As shown in Table 3.4, the overall accuracy (AC), specificity (SP) and MCC of 
our SVM classifier (seeSUMO-SVM) and RF classifier (seeSUMO-RF) are considerably 
higher than those of SUMOsp2 and SUMOplot in the low-threshold predictions. 
SUMOsp2 with its medium threshold gave the prediction strength at 68.31% (43.75% 
sensitivity and 92.87% specificity) and MCC = 0.2449. Our SVM classifier achieved a 
similar level of performance with 67.36% prediction strength, 41.67% sensitivity, 
93.06% specificity and MCC = 0.2361. The RF classifier with the medium threshold 
reached higher performance with 71.60% prediction strength, 51.16% sensitivity, 92.04% 
specificity and MCC = 0.2639. For the high-threshold predictions, the overall accuracy 
and MCC of our RF classifier are also higher than those of SUMOsp2 and SUMOplot. It 
is noteworthy that the MCC values of our RF classifier are the highest in any level of 
threshold predictions. Therefore, the performance of the RF classifier developed in this 
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study compares favorably with SUMOsp2 and SUMOplot for protein sumoylation site 
prediction. 
SUMOpre [9] uses a statistical method for predicting protein sumoylation sites. It 
was not included in the direct comparisons because  w b-based tool was not available 
for the classifier. However, our classifier uses a larger dataset and shows better predictive 
performance. For example, the dataset used by SUMOpre [9] contains 268 sumoylation 
sites, and the predictor reached 96.71% overall accur y and MCC = 0.6364. In the 
present study, the dataset includes 377 sumoylation s tes, and the best RF classifier 
(ΨKXE+/-8, Table 3.1) achieved 97.68% overall accuracy nd MCC = 0.6711 
 
 
Table 3.4 Comparison of classifier performance using a  independent test dataset. 







Low SUMOplot 79.55 68.75 79.95 74.35 0.2196 
 SUMOsp2 83.63 50.00 84.88 67.44 0.1753 
 seeSUMO-SVM 89.48  47.92  91.04  69.48  0.2382 
 seeSUMO-RF 90.09 53.49 91.33 72.41 0.2644 
Medium SUMOsp2 91.11 43.75 92.87 68.31 0.2449 
 seeSUMO-SVM 91.21  41.67  93.06  67.36  0.2361 
 seeSUMO-RF 90.70 51.16 92.04 71.60 0.2639 
High SUMOplot 91.69 50.00 93.24 71.62 0.2916 
 SUMOsp2 94.24 39.58 96.27 67.93 0.3058 
 seeSUMO-SVM 92.49  39.58  94.47  67.02  0.2528 





seeSUMO web server 
To make our classifiers accessible to the biological research community, we have 
developed the seeSUMO web server (http://bioinfo.ggc.or /seesumo/). Users can enter an 
amino acid sequence in the FASTA format, specify the methods, and input the proper 
threshold for prediction of protein sumoylation site.  For prediction using the RF 
classifier, the system encodes the input sequences with the 40 biological features, and 
then calls the randomForest program of the R software package to classify the protein 
sumoylation sites using the most accurate RF model (ΨKXE+/-8, Table 3.1). For 
prediction using the SVM classifier, the system encodes the input sequences with the five 
highly relevant features, and then the best SVM classifier (SVM5, Table 3.2) constructed 
in this work is used to predict sumoylation sites in the query sequence. The seeSUMO 
web server will return the prediction results, including the protein name, potential 
sumoylated sites, classifier outputs and the prediction confidence levers (Figure 3.5). The 
prediction confidence lever is calculated as (1 - sensitivity) for positive predictions, and 









A new machine learning approach has been developed in this study for predicting 
protein sumoylation sites from protein sequence information. Domain-specific 
knowledge in terms of relevant biological features was used for input vector encoding. 
The results suggest that classifier performance is affected by the sequence context of 
sumoylation sites. The highest predictive performance (ROC AUC = 0.9200) has been 
achieved by the Random Forest classifier using twenty residues with the core motif 
ΨKXE in the middle. Moreover, the Random Forest classifiers were found to outperform 
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Support Vector Machine models on the imbalanced dataset. The classifiers developed in 
this study compare favourably in performance with the previous predictors for protein 
sumoylation site prediction. A web server, seeSUMO (http://bioinfo.ggc.org/seesumo/), 
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SEQUENCE FEATURE-BASED PREDICTION OF PROTEIN STABILITY 
CHANGES UPON AMINO ACID SUBSTITUTIONS3 
 
ABSTRACT 
Protein destabilization is a common mechanism by which amino acid 
substitutions cause human diseases. Although several machine learning methods were 
reported for predicting protein stability changes upon amino acid substitutions, these 
previous studies did not utilize relevant sequence features representing biological 
knowledge for classifier construction. In this study, a new machine learning method has 
been developed for predicting protein stability changes upon amino acid substitutions 
from sequence features. Support vector machines were trained with data from 
experimental studies on the free energy change of protein stability upon mutations. To 
construct accurate classifiers, twenty sequence featur s were examined for input vector 
encoding. It was shown that classifier performance varied significantly by using different 
features. The most accurate classifier in this study was constructed using a combination 
of six sequence features. The classifier achieved an overall accuracy of 84.59% with 
70.29% sensitivity and 90.98% specificity. Protein stability changes upon amino acid 
substitutions can be predicted accurately from relevant sequence features. Since 
predictive results at this level of accuracy may provide useful information to distinguish 
between deleterious and tolerant alterations in disease candidate genes, we have 
                                                  
3Teng S, Srivastava AK, Wang L: Sequence feature-basd prediction of protein stability changes 
upon amino acid substitutions. BMC Genomics 2010, 1(Suppl 2):S5. 
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developed a new web server, called MuStab (http://bioinfo.ggc.org/mustab/), to make the 
classifier accessible to the genetics research community. 
 
BACKGROUND 
Amino acid substitutions may cause a series of changes to normal protein 
function, such as geometric constraint changes, physico-chemical effects, and disruption 
of salt bridges or hydrogen bonds [1]. These changes may lead to protein destabilization 
or some abnormal biological functions. Previous studies suggest that each person may 
have 24,000 – 40,000 non-synonymous Single Nucleotid  Polymorphisms (nsSNPs), and 
there are a total of 67,000 – 200,000 common nsSNPs in the human population [2]. These 
nsSNPs give rise to amino acid substitutions in proteins. While most nsSNPs appear to be 
functionally neutral, the others affect protein function and may cause diseases. Yue and 
Moult [3] investigated the effect of amino acid subtitutions on protein stability, and 
estimated that approximately 25% of nsSNPs in the human population might be 
deleterious to protein function. Of the known disease-causing missense mutations, the 
vast majority (up to 80%) resulted in protein destabilization [4]. However, it is not 
feasible to experimentally determine the effect of each human nsSNP on protein stability. 
Rather, computational methods are needed to provide fast and efficient tools for 
examining a large number of nsSNPs for potential disease-causing mutations. 
Machine learning has recently been applied to sequence-based prediction of 
protein stability changes upon amino acid substitutions [5]. The machine learning 
problem can be specified as follows: given the amino acid sequence of a protein and a 
 67
single amino acid substitution, the task is to predict whether the substitution may alter 
protein stability. By using the available data from experimental studies, classifiers can be 
constructed for predicting either the free energy change (∆∆G) of protein stability upon 
mutations or the direction of the change (increased stability if ∆∆G > 0, or decreased 
stability if ∆∆G < 0). Nevertheless, for many biological applications, correctly predicting 
the direction of the stability change (a binary classification problem) is more relevant 
than estimating the magnitude of the free energy change (a regression problem) [5]. 
Capriotti et al. [5] reported an artificial neural network-based method for 
predicting the direction of protein stability changes upon point mutations. The predictor 
was trained with protein sequence alone. It was shown that the sequence-based system 
could be used to complement the available energy-based methods for improving protein 
design strategies. The same research group also develop d support vector machine 
(SVM) models for sequence-based prediction of both the free energy change and the 
direction of the change upon mutations [6]. These SVM models were used to develop the 
I-Mutant2.0 web server, which could predict protein stability increase or decrease at the 
overall accuracy of 77% (based on cross-validation). Interestingly, it was found that the 
sequence-based system was almost as accurate as the structure-based method (80% 
overall accuracy) on the same dataset [6]. This observation was further confirmed by 
Cheng et al., who trained SVMs for predicting protein stability changes from amino acid 
sequence and structural information [7]. More recently, Huang et al. [8] developed the 
iPTREE-STAB web server, which used decision trees with an adaptive boosting 
algorithm to discriminate stabilizing and destabilizing substitutions in protein sequences. 
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Among all the existing methods, iPTREE-STAB achieved the best classifier performance 
in cross-validation tests (82.1% overall accuracy with 75.3% sensitivity and 84.5% 
specificity). 
The above-mentioned studies suggest that protein stability changes can be 
predicted directly from primary sequence data with similar prediction accuracy as 
structure-based methods. The sequence-based approach is particularly appealing since 
structural information is still not available for most proteins. However, little domain-
specific knowledge in terms of biological features was used for classifier construction in 
the previous studies [5]. In the present study, we have examined twenty sequence features 
for classifier construction. Support vector machines (SVMs) have been trained with the 
feature-encoded data instances of protein stability changes upon amino acid substitutions. 
Our results indicate that accurate SVM classifiers can be constructed using relevant 




The dataset used in this study was derived from two previous studies [6, 8], in 
which experimental data for the free energy changes of protein stability upon mutations 
were collected from the ProTherm database [9] . To construct a robust classifier, data 
redundancy was removed and the dataset had less than 25% identity among the amino 
acid sequences. Each data instance in the dataset had the following attributes: amino acid 
sequence, wide-type amino acid identity and sequence position, mutant amino acid 
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identity, pH value, and free energy change. If the free energy change was negative 
(protein destabilization), the instance was labelled as a negative example. Otherwise, the 
instance was labelled as a positive example. The dataset contained 464 positive instances 
and 1,016 negative instances. 
 
Sequence features 
Twenty sequence features were used to code each amino ac d residue in a data 
instance. The sequence features were obtained from Protscale [10] 
(http://expasy.org/tools/protscale.html) and AAindex [11] 
(http://www.genome.jp/aaindex/). These features fall into the following four classes: 
1) Biochemical features: including molecular weight (feature M); side-chain pKa value 
(K); hydrophobicity index (H); polarity (P); and overall amino acid composition (Co). 
Each amino acid has a unique molecular weight (M), which is related to the volume of 
space that a residue occupies in protein structures. Side-chain pKa (K) is related to the 
ionization state of a residue, and thus plays a key role in pH-dependent protein stability. 
Hydrophobicity (H) is important for amino acid side chain packing and protein folding. 
Hydrophobic interactions make non-polar side chains to pack together inside proteins, 
and disruption of these interactions may cause protein destabilization. Polarity (P) is the 
dipole-dipole intermolecular interactions between the positively and negatively charged 
residues. The amino acid composition (Co) was previously shown to be related to the 
evolution and stability of small proteins [12]. 
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2) Structural features: including the conformational p rameters for alpha-helix (A), beta-
sheet (B), and coil (C); average area buried on trasfer from standard state to folded 
protein (Aa); and bulkiness (Bu). Protein secondary st uctures can be divided into alpha-
helix, beta-sheet, and coil conformations. An amino acid often has a different tendency to 
form one of the three types of secondary structures. For instance, amino acids A, I, E, L 
and M tend to be in the alpha-helical conformation, whereas K, N and D are often found 
in beta-sheets. In this study, the conformational parameters reported by Deléage and 
Roux [13] were used for features A, B and C. Feature Aa is another structural parameter, 
which estimates a residue’s average area buried in the interior core of a globular protein 
[14]. Bulkiness (Bu), the ratio of the side chain volume to the length of an amino acid, 
may affect the local structure of a protein [15]. 
3) Empirical features: the protein stability scale based on atom-atom potential (S1); the 
relative protein stability scale derived from mutation experiments (S2); and the side-chain 
contribution to protein stability (S3). Zhou et al.[16] derived two protein stability scales 
from atom-atom potential of mean force based on Distance scaled Finite Ideal-gas 
REference (DFIRE) state (S1) and a large database of mutations (S2). Takano and Yutani 
[17] calculated the transfer Gibbs energy of mutant pro eins, and derived the amino acid 
scale for the side-chain contribution to protein stability (S3) based on data from protein 
denaturation experiments.  
4) Other biological features: including the average flexibility index (F); the mobility of an 
amino acid on chromatography paper (Mc); the number of codons for an amino acid 
(No); refractivity (R); recognition factor (Rf); the relative mutability of an amino acid 
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(Rm); and transmembrane tendency (Tt). The average flexibility index of an amino acid 
(F) was derived from structures of globular proteins  [18]. Feature Mc was derived from 
experimental data by Aboderin [19]. Refractivity (R) refers to protein density and folding 
characteristics [20]. Recognition factor (Rf) is the average of stabilization energy for an 
amino acid [21]. The relative mutability (Rm) indicates the probability that a given amino 
acid can be changed to others during evolution. Featur  Tt is the transmembrane tendency 
scale described by Zhao and London [22]. 
 
Support vector machine training 
Support vector machines (SVMs) are computational algorithms that can learn from 
training examples for binary classification problems. The SVM learning algorithm can be 
described by four basic concepts, including the separating hyperplane, the maximum-
margin hyperplane, the soft margin, and the kernel function [23]. For a typical linear 
classifier, a data instance is represented as an n-dimensional vector, and an (n – 1) 
dimensional hyperplane is used to separate the positive instances from the negative ones. 
However, for non-linear classifiers that are generally applicable to biological problems, a 
kernel function can be used to measure the distance between data points in a higher 
dimensional space. This allows the SVM algorithm to fit the maximum-margin 










 are two data vectors, and γ is a training parameter. A smaller γ value 
makes decision boundary smoother. The regularization factor C, another parameter for 
SVM training, controls the tradeoff between low training error and large margin. 
The SVMlight software package (available at http://svmlight.joachims.org/) was 
used to construct the SVM classifiers in this study. Each training instance was a 
subsequence of w consecutive residues, where w was also called the window size. The 
amino acid substitution site was positioned in the middle of the subsequence, and the 
other (w – 1) neighbouring residues provided context information for the substitution site. 
The input vector was then obtained by encoding eachresidue with one or more biological 
features. The input vector also included the pH value t which the free energy change was 
measured experimentally. In this study, various values of w, γ and C parameters were 
examined to optimize SVM classifier performance. 
 
Classifier evaluation 
This study used a fivefold cross-validation method to evaluate classifier 
performance. Positive and negative instances were randomly distributed into five folds. 
In each of the five iterations, four of the five folds were used to train a classifier, and then 
the remaining one fold was used as the test data to evaluate the classifier. The predictions 
made for the test instances in all the five iterations were combined and used to compute 































=  (4.6) 
where TP is the number of true positives; TN is the number of true negatives; FP is the 
number of false positives; and FN is the number of false negatives. In addition to the 
commonly used performance measures (overall accuracy, sensitivity and specificity), the 
average of sensitivity and specificity or the so-called prediction strength [24, 25] was also 
used for classifier comparison in this study. Matthews Correlation Coefficient (MCC) 
measures the correlation between predictions and the actual class labels. Nevertheless, for 
imbalanced datasets, different tradeoffs of sensitivity and specificity may give rise to 
different MCC values for a classifier.  
We also used the Receiver Operating Characteristic (ROC) curves [26] for 
classifier evaluation and comparison. In this study, the ROC curve was generated by 
varying the output threshold of an SVM classifier and plotting the true positive rate 
(sensitivity) against the false positive rate (1 – specificity) for each threshold value. Since 
the ROC curve of an accurate classifier is close to the left-hand and top borders of the 
plot, the area under the curve (AUC) can be used as a reliable measure of classifier 
performance [27]. The maximum value of AUC is 1, which indicates a perfect classifier. 
Weak classifiers and random guessing have AUC values close to 0.5.  
 74
RESULTS AND DISCUSSION 
Effect of sequence context on classifier performance 
We first constructed a classifier using the three biochemical features, including 
the hydrophobicity index (H), side-chain pKa value (K), and molecular weight (M) of an 
amino acid. These features were previously selected for DNA and RNA-binding site 
prediction [24, 25]. In the initial attempt to construct a classifier for protein stability 
prediction, the window size was set to eleven (w = 11). Different values of SVM training 
parameters were tested, and the optimal parameter sttings were found to be γ = 0.8 and 
C = 1.0. As shown in Table 6.1, the classifier achieved the overall accuracy (AC) of 
81.82% with 74.48% sensitivity (SN) and 85.11% specificity (SP). The prediction 
strength (ST) reached 79.79% with MCC = 0.5843 and ROC AUC = 0.8804. Therefore, 
this SVM achieved similar performance measures as the best existing classifier (iPTREE-
STAB with 82.1% overall accuracy, 75.3% sensitivity and 84.5% specificity) [8]. 
To determine whether classifier performance was affected by the sequence 
context of the substitution site, SVMs were trained with data instances of various window 
sizes. As shown in Table 4.1, protein stability prediction was affected by window sizes. 
The classifier constructed without any context information (w = 1) gave 67.94% 
prediction strength (70.69% sensitivity and 65.20% specificity), MCC = 0.3349 and AUC 
= 0.7425. The prediction strength, MCC and AUC were improved when neighbouring 
residues of the substitution site were included for input encoding. The use of w = 11 gave 
the highest prediction strength (79.79%), MCC (0.5843) and AUC (0.8804), and 
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classifier performance was not further improved by including more neighbouring residues 
(Table 4.1). 
 














1 66.92 70.69 65.20 67.94 0.3349 0.7425 
3 73.91 74.83 73.49 74.16 0.4554 0.7996 
5 77.51 76.67 77.90 77.28 0.5194 0.8512 
7 80.80 76.43 82.83 79.63 0.5750 0.8737 
9 81.28 75.66 83.78 79.72 0.5774 0.8755 
11 81.82 74.48 85.11 79.79 0.5843 0.8804 
13 82.10 71.84 86.67 79.26 0.5824 0.8797 
15 81.45 69.71 86.75 78.23 0.5665 0.8775 
17 81.88 69.50 87.58 78.54 0.5779 0.8799 
19 81.21 68.80 86.98 77.89 0.5627 0.8779 
21 81.29 68.98 86.98 77.98 0.5645 0.8735 
 
 
The effect of sequence context information on SVM classifier performance was 
also demonstrated by using ROC curves. As shown in Figure 4.1, the ROC curve of the 
classifier constructed with w = 11 was clearly better than the SVM trained without any 
context information (w = 1). However, the use of w = 21 did not further improve 
classifier performance. Thus, eleven residues with the substitution site in the middle 
position (w = 11) appeared to provide enough context information for sequence-based 
























Figure 4.1 ROC curves to show the effect of context information on prediction of protein 
stability changes upon amino acid substitutions. 
 
Relevant sequence features for classifier construction 
Many sequence features are available for encoding amino acid residues. To 
determine which features were relevant for protein stability prediction, we constructed 
SVM classifiers using each of the twenty sequence features listed in Table 4.2 for input 
encoding (w = 11). The results were obtained with the training parameters, γ = 0.8 and C 
= 1.0. It was found that classifier performance varied significantly by using different 
features. As shown in Table 6.2, the highest level of AUC (0.8835) was achieved by 
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using the empirical feature S3 for input encoding. This classifier reached the prediction 
strength at 79.67% (72.19% sensitivity and 87.15% specificity) and MCC = 0.5922. 
However, the highest prediction strength at 80.28% (75.62% sensitivity and 84.94% 
specificity) with MCC = 0.5919 and AUC = 0.8777 was chieved by using amino acid 
bulkiness (Bu) for input encoding. In contrast, theus  of the average flexibility index (F) 
for input encoding resulted in the lowest prediction strength at 62.02%, MCC = 0.2226 
and AUC = 0.6728 (Table 4.2).  
 












H 75.88 71.62 77.79 74.70 0.4728 0.8237 
K 73.29 73.90 73.02 73.46 0.4402 0.7925 
M 68.06 73.52 65.62 69.57 0.3629 0.7480 
P 75.94 71.24 78.04 74.64 0.4718 0.8234 
Co 70.18 71.62 69.53 70.58 0.3838 0.7586 
A 76.41 74.29 77.36 75.82 0.4904 0.8206 
B 78.18 74.48 79.83 77.15 0.5199 0.8503 
C 72.18 71.05 72.68 71.86 0.4116 0.7847 
Aa 79.12 76.57 80.26 78.41 0.5431 0.8459 
Bu 82.06 75.62 84.94 80.28 0.5919 0.8777 
S1 69.82 70.86 69.36 70.11 0.3756 0.7754 
S2 70.24 72.19 69.36 70.78 0.3875 0.7665 
S3 82.53 72.19 87.15 79.67 0.5922 0.8835 
F 61.41 63.62 60.43 62.02 0.2226 0.6728 
R 66.47 65.14 67.06 66.10 0.3008 0.7140 
Mc 78.35 73.52 80.51 77.02 0.5202 0.8417 
No 69.82 74.86 67.57 71.22 0.3944 0.7656 
Rf 62.06 73.71 56.85 65.28 0.2831 0.6889 
Rm 75.94 69.90 78.64 74.27 0.4672 0.8118 
Tt 83.59 66.48 91.23 78.86 0.6035 0.8704 
 78
Figure 4.2 shows the ROC curves of the best and worst classifiers (based on 
AUC) that were constructed using the individual sequence features. Also shown in Figure 
6.2 is the ROC curve of the SVM classifier constructed with the K feature, which gave 
























Figure 4.2 ROC curves to show the different performance levels of classifiers constructed 
using individual sequence features. 
 
The results suggest that a variety of sequence features are relevant for predicting 
protein stability changes upon amino acid substitutions. Of the five biochemical features 
 79
(H, K, M, P and Co), the hydrophobicity index (H) gave the best predictive performance 
at 74.70% prediction strength (71.62% sensitivity and 77.79% specificity), MCC = 
0.4728 and AUC = 0.8237 (Table 4.2). Hydrophobicity is a key factor in amino acid side 
chain packing and protein folding. Hydrophobicity changes owing to amino acid 
substitutions may cause proteins not to fold into stable conformation, and thus result in 
protein destabilization. 
Of the structural features (A, B, C, Aa and Bu), bulkiness (Bu) gave rise to the 
highest prediction strength at 80.28% with MCC = 0.5919 and AUC = 0.8777. In 
contrast, the classifier using the conformational parameter for coil (C) had the relatively 
low performance with 71.86% prediction strength, MCC = 0.4116 and AUC = 0.7847 
(Table 4.2). The possible explanation is that since coils are often unstructured and 
flexible, amino acid substitutions in the coil region may not cause significant changes in 
protein structure and stability. 
The empirical features (S1, S2 and S3) are protein stability scales based on 
experimental data. Interestingly, when used for SVM classifier construction, these 
features did not give significantly better performance than the other sequence features. 
While the use of the S3 feature (side-chain contribu ion to protein stability) resulted in 
the highest level of AUC (0.8835) with 79.67% prediction strength and MCC = 0.5922, 
the other two empirical features (S1 and S2) were much less accurate for predicting 
protein stability changes (Table 4.2). Thus, it is po sible that the empirical features do not 
capture all the information about the determinants of protein stability. 
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Of the other biological features, transmembrane tendency (Tt) achieved the 
highest level of MCC (0.6035) with 78.86% prediction strength and AUC = 0.8704 
(Table 4.2). The feature Mc (the mobility of an amino acid on chromatography paper) 
also gave rise to relatively high classifier performance (77.02% prediction strength, MCC 
= 0.5202 and AUC = 0.8417). Therefore, multiple features from each of the four feature 
classes achieved high performance for predicting protein stability changes upon amino 
acid substitutions. It might be possible that classifier performance could be further 
improved by combining several sequence features for input encoding. 
 
Use of multiple sequence features to improve classifier performance 
To examine whether classifier performance could be further improved, we first 
used all the 20 sequence features for input encoding. Surprisingly, the resulting classifier 
was not as accurate as some of the SVMs trained with single features (Table 4.3). While 
the best single feature S3 gave rise to 79.67% prediction strength with MCC = 0.5922 
and AUC = 0.8835, the classifier using all the 20 features achieved only 75.45% 
prediction strength with MCC = 0.5791 and AUC = 0.8690. The possible explanation is 
that some of the 20 features contain redundant or correlated information, which may 
cause classifier performance degradation. 
We then constructed SVM classifiers by combining some of the best single 
features for input encoding. Interestingly, none of these feature combinations gave rise to 
better classifier performance than the best single feature S3 (Table 4.3). For example, the 
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classifier constructed using the best six single features (S3, Bu, Tt, B, Aa, and Mc) 
achieved only 77.54% prediction strength with MCC = 0.5993 and AUC = 0.8737. 
 













S3 82.53 72.19 87.15 79.67 0.5922 0.8835 
S3, Bu 83.41 68.00 90.30 79.15 0.6019 0.8821 
S3, Bu, Tt  82.88 61.90 92.26 77.08 0.5822 0.8725 
S3, Bu, Tt, B 83.65 62.10 93.28 77.69 0.6009 0.8768 
S3, Bu, Tt, B, Aa 83.65 61.90 93.36 77.63 0.6009 0.8743 
S3, Bu, Tt, B, Aa, Mc 83.59 61.71 93.36 77.54 0.5993 0.8737 
All 20 features 82.88 56.00 94.89 75.45 0.5791 0.8690 
 
To determine whether any combinations of the sequence features could improve 
classifier performance, we performed a brute-force search for the optimal feature subset. 
As shown in Table 4.4, classifier performance based on AUC was improved slightly but 
steadily when more features were used for input encodi g. Among all the two-feature 
combinations, the biochemical feature Co (overall amino acid composition) together with 
the structural feature Bu (bulkiness) achieved the best classifier performance based on 
AUC (0.8872) with 80.54% prediction strength and MCC = 0.6057. These performance 
measures are slightly better than those of the empirical feature S3, a protein stability scale 
based on experimental data [17]. Significantly, the feature Co is also included in all the 
other feature subsets shown in Table 4.4, suggesting that the overall amino acid 
composition is highly relevant for sequence-based pr iction of protein stability changes. 
For instance, the best four-feature subset contains the biochemical features Co and H 
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(hydrophobicity index), the structural feature B (conformational parameter for beta-
sheet), and the empirical feature S3. The classifier achieved 80.16% prediction strength 
with MCC = 0.6231 and AUC = 0.8940 (Table 4.4). 
 













S3 82.53 72.19 87.15 79.67 0.5922 0.8835 
Bu, Co 83.00 74.10 86.98 80.54 0.6057 0.8872 
B, Co, S3 84.12 69.33 90.72 80.03 0.6194 0.8924 
B, Co, H, S3 84.29 69.33 90.98 80.16 0.6231 0.8940 
A, Aa, B, Co, P 84.47 70.48 90.72 80.60 0.6287 0.8954 
A, Aa, B, Co, No, P 84.59 70.29 90.98 80.63 0.6310 0.8961 
 
As shown in Table 4.4, the highest performance measur s were obtained by using 
the optimal subset of six features, including the biochemical features Co and P (polarity), 
the structural features A (conformational parameter for alpha-helix), B and Aa (average 
area buried on transfer from standard state to folded protein), and the other biological 
feature No (number of codons for an amino acid). Classifier performance was not further 
improved significantly by including additional sequence features (data not shown). 
Interestingly, the optimal feature subset did not include the best single feature S3. The 
classifier constructed using the optimal feature subset achieved 80.63% prediction 
strength with MCC = 0.6310 and AUC = 0.8961. In Figure 6.3, this classifier’s ROC 
curve is compared with those of two other classifiers, one constructed using the best 





















A, Aa, B, Co, No, P
All 20 features
 
Figure 4.3 ROC curves for sequence-based prediction of protein stability changes using 
multiple sequence features. 
 
The results suggest that classifier performance can be enhanced by combining 
certain sequence features for input encoding. The optimal six-feature subset contains 
sequence features from different classes, especially biochemical features and structural 
features. Each of these features may not be an accurate scale of protein stability, but 
when combined, they can outperform the best empirical feature (S3) for predicting 
protein stability changes upon amino acid substitutions. 
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Web server description 
To make the accurate SVM classifier accessible to the biological research 
community, we have developed the MuStab web server (http://bioinfo.ggc.org/mustab/). 
Users can enter an amino acid sequence in FASTA format, and specify the position and 
the identity of the substituting residue. The system encodes the input sequence with the 
optimal feature subset, and then calls the svm_classify program of the SVMlight software 
package to classify the protein stability changes upon the amino acid substitution using 
the best SVM model developed in this study. 
The output report returned from the MuStab web server includes the information 
about the query sequence and amino acid substitution, the prediction result, and the 
prediction confidence. The prediction result indicates either decreased or increased 
protein stability. The prediction confidence is based on the SVM output and computed as 
(1 – s), where s is the expected sensitivity for positive predictions or the expected 
specificity for negative predictions if the SVM outp  is used as the threshold in the ROC 
analysis (Figure 4.3). An example output report returned from the MuStab web server is 
shown in Figure 4.4 for the G56S substitution of spermine synthase (PDB: 3C6K), which 
causes X-linked Snyder-Robinson syndrome [28]. The substitution is predicted to 









In this study, we have developed a machine learning method for predicting 
protein stability changes upon amino acid substitutions. The novelty of our method lies in 
the use of sequence features representing biologica knowledge for input encoding. 
Twenty sequence features were examined for SVM classifier construction, and several of 
them were shown to be highly relevant for protein stability prediction. However, the 
SVM classifier constructed using all the twenty features did not show high predictive 
performance. We thus used a wrapper approach for feature selection, and identified the 
optimal subset of six sequence features for input encoding. The best classifier achieved 
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the overall accuracy of 84.59% with 70.29% sensitivity and 90.98% specificity. This 
SVM classifier is compared favorably in performance with the previously published 
models for protein stability prediction. Since the previous studies did not utilize the 
biological knowledge for classifier construction, our method can be used to complement 
the existing methods to predict the consequences of amino acid alterations in disease 
candidate genes and may provide useful information for elucidating the molecular 
mechanisms of human genetic disorders. We have thus developed the MuStab web server 
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MODELING EFFECTS OF HUMAN SINGLE NUCLEOTIDE POLYMORPHISMS 
ON PROTEIN-PROTEIN INTERACTIONS4 
 
ABSTRACT 
A large set of 3D structures of 264 protein-protein complexes with known non-
synonymous SNPs (nsSNPs) at the interface was built using homology-based methods. 
The nsSNPs were mapped on the proteins’ structures and their effect on the binding 
energy was investigated with CHARMM force field and continuum electrostatic 
calculations. Two sets of nsSNPs were studied: disease annotated (OMIM) and non-
annotated (non-OMIM). It was demonstrated that OMIM nsSNPs tend to destabilize the 
electrostatic component of the binding energy, in co trast with the effect of non-OMIM 
nsSNPs. In addition, it was shown that the change of the binding energy upon amino acid 
substitutions is not related to the conservation of the net charge, hydrophobicity or 
hydrogen bond network at the interface. The results indicate that, generally, the effect of 
nsSNPs on protein-protein interactions cannot be predicted from amino acids’ physico-
chemical properties using the structure-based methods alone, since in many cases a 
substitution of a particular residue with another amino acid having completely different 
polarity or hydrophobicity had little effect on the binding energy. Analysis of sequence 
conservation showed that nsSNP at highly conserved positions resulted in large variance 
of the binding energy changes. In contrast, amino acid substitutions corresponding to 
nsSNPs at non-conserved positions, on average, were not found to have a large effect on 
                                                  
4Teng S, Kundrotas P, Madej T, Panchenko A, Alexov E: Modeling effects of human SNPs on 
protein-protein interactions. Biophysics. J. 2009, 96(6):2178-2188. 
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binding affinity. pKa calculations were performed and showed that amino acid 
substitutions could change the wild type proton uptake/release and thus resulting to 
different pH-dependence of the binding energy.  
 
INTRODUCTION 
Each individual possesses unique characteristics reflecting their genotype, i.e. the 
uniqueness of the individual’s DNA [1]. For example, almost all nucleotide bases 
(99.9%) are exactly the same in all people; however, the remaining 0.1% account for 
about 1.4 million individual-specific differences (ingle nucleotide polymorphism: SNP) 
that occur in humans. These differences may be within the coding or non-coding regions 
of DNA and may or may not result in amino acid changes, which, in turn, can either be 
harmless or disease causing [2]. From a computational biophysics point of view, SNPs 
resulting in amino acid changes (non-synonymous SNP: nsSNP) are of particular interest 
because such changes should affect the stability of pr teins and protein-protein 
complexes. 
From a biological perspective, the major factor contributing to the complexity of 
biological systems is the high degree of connectivity on the molecular scale. In particular, 
many proteins responsible for cellular functions rely on interactions with other proteins to 
perform these functions. If the structures of the corresponding protein-protein complexes 
are available, then we will have the opportunity to apply theoretical biophysical methods 
to model the energetics of protein-protein complexes [3-9] and apply the results in 
structure-based drug design [10]. Thus, understanding protein-protein interactions and 
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their roles in cell function will help reveal the molecular mechanisms of protein 
recognition and model of the effect of perturbations n biological network, in particular, 
the effects of nsSNPs on protein-protein interactions [11-14].   
The effects caused by nsSNPs can be broadly grouped into four distinctive 
categories [15] (although the effects may be mutually dependent) depending on what type 
of system or process have been affected by nsSNPs: (a) protein folding, stability, 
flexibility and aggregation; (b) functional sites, reaction kinetics and dependence on the 
environmental parameters, such as pH, salt concentration and temperature; (c) protein 
expression and subcellular localization and; (d) protein-small molecule, protein-protein, 
protein-DNA and protein-membrane interactions (see review and references within [15]). 
Among these categories, the effect of nsSNPs on protein stability [16-18] attracted most 
of the attention of scientific community. The mechanisms of the effect of nsSNPs on 
protein stability could vary from geometrical constraints (the mutation of a small side 
chain to a bulky side chain in the protein interior), to physico-chemical effects 
(replacement of hydrophobic residue with polar residue), to the reversal of a charge 
within a salt bridge, or to the disruption of hydrogen bonds [19]. For example, the 
nsSNPs resulting in changes of functionally important residues should be almost always 
deleterious as they would block protein function [20] [21]. However, since there are only 
a few functional residues within an entire protein sequence, the probability for such 
mutations is low [22]. The possibility of a nsSNP affecting the subcellular location of a 
corresponding protein was reported in a recent study which showed that in about one 
percent of the cases the disease is caused by protein subcellular delocalization [23]. In 
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addition to the above mentioned effects, nsSNPs can change the kinetics of the 
corresponding reactions as it was experimentally shown in case of patients with chronic 
lymphocytic leukemia [24],  inflammatory diseases [25] or to affect the pharmacokinetics 
[26], however modeling these effects is computationally difficult. However, although the 
studies of consequences of nsSNPs on proteins have dr wn much attention recently, the 
effect of nsSNPs on protein-protein interactions hanot been extensively investigated. 
Perhaps this is due to the lack of sufficiently many 3D structures of protein-protein 
complexes for which nsSNPs are known.  
The progress recently made in experimental 3D structu e determination, led by 
the Structural Genomic Initiatives [27], in addition to advances in computational 
modeling [28, 29] made it possible to predict the eff cts of nsSNPs by mapping them on 
the corresponding structures or on the protein and protein-protein models. Indeed, 
structural information was used in many studies to reveal the role of SNPs on protein 
function and stability. A recent study on human nsSNPs and disease-associated mutations 
in orthologous genes revealed that approximately 70% of disease-associated mutations 
were in protein sites that most likely affect protein function [30-33]. Moreover, it was 
found that disease mutations are much more likely to occur at sites with low solvent 
accessibility [32]. Recently, a structure-based approach that models residue-residue 
interaction networks was reported [34]. It applied graph theoretical measures to predict 
the residues that are important for structural stability. These results imply that nsSNPs 
impact protein function and stability by affecting their structures, which in turn might 
cause changes in protein-protein or protein-ligand interactions. 
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It should be mentioned that most of the efforts in the field so far have been aimed 
at predicting deleterious mutations, since such predictions could be used for early 
diagnostics and potential drug discovery [23, 31, 32, 35-38]. However, the goals of our 
study are: (a) to investigate the possibility that disease-causing and harmless nsSNPs 
affect protein-protein interactions differently, and (b) to reveal the basic principles of the 
effects of naturally occurring interfacial nsSNPs on protein-protein interactions. The 
rationale behind our approach is that any mutation at a protein-protein complex interface 
should, in principle, affect somehow the binding energy and even harmless nsSNPs can 
also cause dramatic changes in the phenotype resulting in natural differences among 
individuals. To deduce the effect of nsSNPs on protein function, further investigation of 
the effect of nsSNPs on protein-protein interaction network is needed, combined with 
detailed analysis of the importance of the perturbed interactions for normal cellular 
function.  
In this study, we use homology modeling to construct 3D models of a large 
number of protein-protein complexes (264) with know nsSNPs at their interfaces.  The 
effect of amino acid substitution resulted from nsSNPs on the protein-protein binding 
energy was calculated using a standard force field (CHARMM [39]), in contrast to 
previous studies that applied descriptors or semi-empirical functions. In addition, specific 
attention was paid to possible ionization changes and charge reorganization caused by the 
nsSNP mutations. The calculated effects are grouped into categories that describe several 
distinctive mechanisms of nsSNPs affecting the energetics of protein-protein interactions. 
The role of charge relaxation is also investigated. 
 94
METHODS 
Sequence alignment, template detection and model building 
The first task was to extract query amino acid sequences associated with nsSNPs 
and to search for available 3D structures or for 3D structures that are homologous to the 
query sequences. The locus-id files for humans were downloaded from build 126 of the 
dbSNP database, which contains the SNPs associated with gene names and locations on 
genes. These files also included accessions for protein sequences associated with the 
SNPs. The protein sequences, which were found to be associated with SNPs, were 
compared against the set of human protein structures (potential structural templates) 
(NCBI MMDB) [40], using Blast algorithm [41]. Those human structures which were 
found at an E-value of 10e-5 or better were kept resulting in 5.6 millions alignments. If a 
3D structure of a query protein was available, no modeling was required. Query proteins 
that matched any of the entries in the OMIM database [42-44] were marked as 
“annotated” disease-causing. The rest of the entries w re considered undetermined with 
respect to possible disease association and are referred to in the manuscript as “non-
annotated” or “non-OMIM”.   
At the second stage of processing, additional criteria were used requiring that 
80% of the query sequence to be mutually aligned with the structural template (nsSNPs 
that were not mapped in the alignment were discarded). Only templates corresponding to 
protein-protein (or domain-domain) complexes were us d for modeling 3D structures of 
nsSNP containing sequences. During this procedure, we recorded whether or not the SNP 
was on the interface for each chain/domain pair. It was done using query-template Blast 
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alignments. Interface residues were defined as those being 8Å from each other (distance 
was measured between C-alpha atoms) on different chains/domains[45]. These positions 
were flagged as interfacial residues. 
The detected templates and corresponding sequence alignments were used as 
input for the homology modeling. The 3D models were built with program NEST using 
the sequence alignment between queries and structural emplates  [46]. Identical 
alignments were discarded. The number of models buit for different degrees of modeling 
difficulty were as follows: (1) 1257 models were built by side chain replacement where 
query and template sequences differed only by a few residues and the models were built 
by mutating corresponding residues in the original chain and (2) 5274 models were built 
with the NEST program. Because of the restrictive alignment criteria applied above, in 
most of the cases, the alignment had very few gaps/insertions, and thus the models were 
very close to the template structures. In total, 6531 protein models were constructed 
which corresponded to the first allele (the first allele in case of OMIM is the dominant 
allele, while in case of non-OMIM it is simply the first allele in the list). Then the 
monomeric proteins models were joined to the corresponding partners using the 3D 
structure of template protein-protein complex. The models of complexes were then 
evaluated according to the flagged interfacial positions, and only models with nsSNPs 
occurring at the interface of protein-protein complexes were retained for our study, 





The structures of the 264 complexes were subjected to the TINKER package [47] 
using the CHARMM27 force field parameters [39]. The minimization was done running 
the TINKER’s minimize.x module. The minimize.x module performs energy minimization 
using the Limited Memory BFGS Quasi-Newton Optimization algorithm [47]. The 
implicit solvent was modeled using the Still Generalized Born model [48], and the 
internal dielectric constant was set to 1.0 to be consistent with the CHARMM27 force 
field parameters [49].  The convergence criteria applied was RMS gradient per atom = 
0.01. For energy minimization calculations, we utilized a High Throughput Distributed 
Computing Resource, CONDOR, originally developed at the University of Wisconsin-
Madison (www.cs.wisc.edu/condor), which is now available at Clemson University with 
more than 1,080 single CPUs of computational power.  
The minimized 3D structures of the complexes with amino acids corresponding to 
the first reported allele in the dbSNP database were then used to generate the 
corresponding nsSNP mutations. Utilizing the SCAP program [50], the mutations, 
corresponding to either the second allele in the dbSNP database or the disease-causing 
nsSNP in OMIM database, were introduced using the above minimized model 3D 
structures, while keeping the rest of the structure rigid, including the hydrogen atoms. In 
case of homooligomeric-complexes, the nsSNP mutations were introduced on both 
monomers. Then, the resulting 3D structures were minimized again with TINKER using 
the same protocol that was described above.  
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Binding energy calculations 
The binding energy was calculated with the so-called rigid body approach 
keeping the structures of the monomers as they werein the complexes. Such an approach 
is advantageous because the internal mechanical energi s of the unbound and bound 
monomers are the same and do not have to be included in the calculations of the binding 
energy. Thus, the single point calculations result in binding energy: 
 
 )()()()( BGAGcomplexGbindingG ∆−∆−∆=∆∆     (5.1) 
 
where ∆G(complex), ∆G(A) and ∆G(B) are the unfolding free energy for the complex, 
monomer A and monomer B, respectively. The total binding energy and its two 
components (electrostatics and van del Waals) were analysed. The electrostatic 
component of the binding energy is the sum of the Coulombic and reaction field energies 
as described in detail in [51, 52]: 
 
)()()( rxnGcoulGXGel ∆+=∆      (5.2) 
 
where X stands for the complex, A and B monomers, respectively. G(Coul) is the 
Coulombic interaction energy, and G(rxn) is the reaction field energy, which is calculated 
with Delphi program [51, 52].  
The total binding energy is: 
 
)()()()( elGvdWGbondsGXGtot ∆+∆+∆=∆    (5.3) 
 
where ∆G(bonds) are the bonded energy terms, ∆G(vdW) is the van der Waals energy and 
∆G(el) is the Coulombic interactions and solvation energy calculated with the 
Generalized Born (GB) model. However, since we adopted the rigid body approach, 
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∆G(bonds) for the complexes and free monomers is the same and c cels in eq. (5.3). All 
of the above energy terms were calculated with the analyze.x module in TINKER. The 
non-polar component of the binding energy was not icluded in the calculations because 
the single point mutation is not expected to change the binding interface significantly. 
Changes in protein stability caused by the nsSNP mutation were calculated with 
respect to the energy of the target (the first repoted allele or wild type allele in case of 
OMIM nsSNPs) protein. The corresponding quantity is ∆∆∆G(snSNP), as described 
below:  
):():()( bindingsnSNPGbindingtargetGsnSNPG ∆∆−∆∆=∆∆∆    (5.4) 
The changes of the total binding energy (∆∆∆Gtot(nsSNP)), as well as the change 
of its vdW (∆∆∆Gvdw(nsSNP)) and electrostatic (∆∆∆Gel(nsSNP)) components are 
analyzed in this work. If the change is negative, this indicates that the nsSNP mutation 
weakens the affinity and destabilizes the complex, while if the change is positive then the 
mutant binding is tighter.  
 
Multiple sequence alignment 
Protein sequences from different species were downloaded from the NCBI Entrez 
database, using GENE search option and submitting each of the gene’s ID as a query. 
Only cases for which a protein was found in more than four species were considered, and 
the MSAs were built resulting in 227 out of the total 264 sequences. We used EBI’s 
ClustalW2 web service (http://www.ebi.ac.uk/Tools/clustalw2/index.html) to perform 
multiple sequence alignments (MSA). 
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pKa calculations of the ionizable states and proton uptake/release  
The pKa values of the ionizable groups were calculated using the Multi 
Conformation Continuum Electrostatics (MCCE) method as previously described [53-
55]. Recently, we demonstrated that MCCE can be utilized to calculate pKa’s using 3D 
structures that were built by homology [56]. Calculations were performed for all 264 
protein complexes corresponding to the first allele, and another set of pKa calculations 
were done for the protein complexes with corresponding nsSNP mutation. The 
calculations were also performed on the corresponding unbound monomers, which 
structures were taken from the corresponding protein-protein complex. These results 
were used to predict the changes of the titratable groups’ ionization states caused by 
complex formation. For each complex, we calculated the difference of the net charge 
(∆q(X)) of the complex and of the unbound monomers, called proton uptake/release: 
 
 ):():():()( BXqAXqcomplexXqXq −−=∆     (5.5) 
 
where X is the first allele or nsSNP variant, and q is the net charge of the complex 
and of monomer A and B, respectively, calculated with MCCE at a pH of 7.0. We chose 
a pH of 7.0 because there was no information of what is the physiological pH for each of 
the proteins studied in this manuscript. In addition, we analyzed the proton uptake/release 
difference between complexes with the first allele and the nsSNP variant: 





 The P-values were calculated performing t-test [57-59]. The distributions of the 
corresponding changes of the binding energy and its components in case of OMIM and 
non-OMIM sets were checked against the null hypothesis. Large P-value indicates that 
the corresponding distribution is similar to the normal distribution (null hypothesis), 
while small P-value points out a deviation from random distribution. Typical cut-off for 
P-value is 0.01, i.e. distribution with P-value smaller than 0.01 is considered significantly 
different from random. The distribution of the variance of ∆∆∆Gtot(nsSNP) and 
∆∆∆Gel(nsSNP) was checked against the null hypothesis that assumes equal variances. 
The SI% scale was divided into five bins, corresponding to cases with SI% smaller than 
20%, 20% < SI% <40%, 40% < SI% < 60%, 60% < SI% < 80, and 80% < SI% < 100%. 
The variance of the corresponding energies was calculated within each of the bins and the 
resulting P-value evaluated. In case of ∆∆q, six bins were considered: 0.00 < ∆∆q < 0.05, 
0.05 < ∆∆q < 0.10, 0.10 < ∆∆q < 0.15, 0.15 < ∆∆q < 0.20, 0.20 < ∆∆q < 0.25 and ∆∆q > 
0.25.  Then, the variance of the corresponding energies within these bins and the P-value 
were calculated.  
 
RESULTS AND DISCUSSION 
Distribution of binding energy 
The changes in the total binding energy and its electrostatic and vdW components 
due to the nsSNPs were calculated for all complexes in the dataset (Figure 5.1, Table 
5.1). The distributions of ∆∆∆Gtot(snSNP) for OMIM and non-OMIM cases are shown in 
 101 
Figure 5.1a. It can be seen that the distributions have similar shapes, showing slight 
tendency toward negative values. The mean values of lectrostatic (∆∆∆Gel(snSNP)) and 
vdW (∆∆∆Gvdw(snSNP)) components of the binding energy changes are statistic lly 
different for OMIM and non-OMIM cases (P-values are less than 0.006 and 0.01 
respectively), although this is not the case for the total binding energy. Figure 5.1b shows 
the distribution of ∆∆∆Gel(snSNP) for both OMIM and non-OMIM cases. One can see 
the long negative tail of the distribution of OMIM cases for which nsSNP substitutions 
destabilize binding. Moreover, the mean of OMIM distribution of electrostatic energy is 
significantly different from zero and shifted towards negative values although this is not 
the case for non-OMIM distribution of electrostatic component (Table 5.1). This 
indicates that, overall, there is a tendency for OMIM nsSNP substitutions to weaken 
electrostatic component of the binding energy, although there are many examples where 
disease nsSNPs make binding tighter as well. The effect is less pronounced for the total 
binding energy.   
 
Table 5.1: Parameters of distributions of total binding energy difference and its 
components together with the corresponding P-values (the null hypothesis that mean 
value is greater or equal to zero is rejected if P-value is less than 0.01) 
 
Group No ∆∆∆Gtot ∆∆∆Gvdw ∆∆∆Gel 
mean std P-value mean std P-value mean std P-value 
OMIM 45 -1.65 3.80 0.003 -1.03 3.32 0.02 -2.35 5.51 0.003 
Non-OMIM 219 -0.70 4.36 0.009 0.14 3.03 0.75 -0.45 4.39 0.06 
Polar (P) 62 -0.27 3.77 0.28 0.38 3.94 0.77 -0.83 4.74 0.09 
Charge (C) 76 -2.01 6.38 0.004 -0.33 2.25 0.1 -1.37 6.59 0.04 
Small (S) 94 -0.74 2.39 0.002 -0.03 2.49 0.45 -0.78 2.58 0.002 
Hydrophobic 
(H) 




Figure 5.1: ROC Distribution of ∆∆∆Gel(nsSNP) and ∆∆∆Gtot(nsSNP) for OMIM and  
non-OMIM cases. OMIM: black bars, non-OMIM: white bars. 
 
  From an electrostatic point of view, replacing the wild type amino acid (dominant 
allele) at a protein-protein interface with another amino acid (amino acid which 
corresponds to nsSNP) is expected to be a destabilizing event. Indeed, in our previous 
study of 654 protein-protein and domain-domain complexes, we demonstrated that the 
electrostatic component of the binding energy tend to be optimized [60] with respect to 
random shuffling of the amino acid sequences of the corresponding binding partners. 
Thus, since wild type (dominant allele) interactions across the interface are optimized, 
any change should make the binding affinity weaker. Indeed, the destabilization effect 
upon disease substitutions is the most pronounced in case of electrostatic component of 
binding energy (∆∆∆Gel distributions is shifted toward negative values with P-value of 
less than 0.003). However, the tendency of OMIM mutations to destabilize electrostatic 
component of the binding energy is not very strong which perhaps stems from the fact 
that nsSNP substitutions are not random, rather they ar  constrained mutations accepted 
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by the cell. At the same time, for non-OMIM substitutions the electrostatic component 
should be optimized for both alleles and consequently the mean of ∆∆∆Gel(nsSNP) is not 
statistically significant different from zero (P-value is 0.06). 
  Despite the differences, in majority of the cases, both OMIM and non-OMIM 
substitutions were calculated to have little effect on the binding. Since we investigate 
nsSNP substitutions at the interface of protein complexes, such an observation deserves 
further investigation. The next sections investigate possible patterns and correlations 
between different types of amino acid substitutions a d their calculated effects on the 
binding energy.  
 
Effect of nsSNPs on binding energy with respect to amino acid characteristics 
In this section, four different classes of amino acids were considered based on the amino 
acids’ physico-chemical properties: polar (S, T, H, N, Q, Y), charged (E, D, K, R), 
hydrophobic (W, I, L, M, F) and small (P, A, G, C, V). We adopt such a simplified 
classification to ensure that each class has enough representatives in our dataset. Of 
course, many other classifications exist, including more detailed definitions of the 
subgroups. Below we investigate the effects of nsSNP mutations on the ∆∆∆Gtot(snSNP), 
∆∆∆Gvdw(nsSNP) and ∆∆∆Gel(nsSNP) separately for each class (more detailed analysis 
including analysis of the effects of substitutions between classes is given in the 





Figure 5.2: Illustration of nsSNPs at interface of protein-protein complexes. (a) TTR 
(transthyretin, Gene ID: 4507725)   Red: A Chain, Blue: E Chain. Green: Ser in A85, 
Yellow: F in A85, Magenta: N in E63. (b) DYNLRB1 (Roadblock-1, Gene ID: 7661822) 
Red: A Chain of target, Light Red: A Chain of SNP variants. Blue: B Chain of target, Sky 
Blue: B Chain of SNP variant, Green: K in A75, Yellow: E in A75, Magenta: D in B61 of 
target, Pink: D in B61 of  SNP variant.  (c) HBB (beta globin, Gene ID:  4504349)     
Red: B Chain, Blue: C Chain. Green: V in B34, Yellow: L in B34. (d) GSTM2 
(glutathione S-transferase M2, Gene ID: 4504175)     Red: A Chain, Blue: B Chain. 







Binding energy changes caused by a substitution of a p lar amino acid 
There are 62 cases in our dataset for which a polar residue corresponding to the 
first allele and located at the interface of the protein-protein complex is substituted by 
other variant (Table 5.1). Overall, there is no stati tically significant bias for energy to be 
shifted upon substitution towards lower or higher values.   
From an electrostatic point of view, a polaranother amino acid substitution 
tends to be an unfavorable event in the majority of cases (P-value=0.09). In another 
words, removal of a polar group at the interface, dspite structural refinement, makes 
electrostatic binding energy less favorable. Further analysis of such cases showed that a 
removal of a polar residue disturbs the hydrogen bod network at the interface. 
Substitution of a polar residue with either a small, charged or hydrophobic groups tends 
to make electrostatic component of binding weaker. A small residue will create 
energetically unfavorable cavities, a charged residue will pay large desolvation penalty 
and a hydrophobic residue will not be able to provide the required hydrogen bonds. 
However, exceptions are cases when a polar group is replaced by another polar residue 
whose side chain can satisfy the required geometry. In the last case, the electrostatics may 
not change or even become more favorable.  
A particular example of polarhydrophobic substitution is shown in Figure. 2a. 
It demonstrates that removal of a polar residue and substitution with a hydrophobic 
residue results in the placement of the hydrophobic side chain in a polar environment, an 
event that weakens the binding affinity. A typical case is Transthyretin (TTR), which is a 
plasma protein that binds retinol and thyroxine. Many distinct forms of amyloidosis are 
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related to different nsSNPs in TTR. For example, th nsSNP (refSNP ID: rs11541784) 
results in a change of the polar (Ser) residue intoa hydrophobic residue (Phe). The 
nsSNP Phe residue is located in a polar environment and reduces the binding affinity by 
0.717 kcal/mol. 
 
Binding energy changes caused by a substitution of a charged amino acid 
 There are 76 cases in our dataset in which a charged esidue located at the 
interface of the target protein-protein complex is substituted in the nsSNP variant (Table 
1). The values of the means of ∆∆∆Gtot(nsSNP) and its electrostatic component 
∆∆∆Gel(nsSNP) are negative and this bias is statistically signifcant (P-values 0.004 and 
0.04, respectively) which means that the target protein-protein complexes are more stable 
compared to the nsSNP variants.  
 Substituting a charged with another residue is, overall, an unfavorable event with 
respect to protein-protein association (Table 5.1). Removal of a charged residue that 
forms a salt bridge across the interface in the target complex leaves the charged partner 
without favorable pair-wise interactions. The remaining charged residue pays a huge 
desolvation penalty upon complex formation, which in the nsSNP variant may not be 
compensated by favorable pair-wise interactions. This provides an intuitive explanation 
why distributions of both the ∆∆∆Gtot(nsSNP) and ∆∆∆Gel(nsSNP) are shifted toward 
negative values .  
 The mutation of a charged amino acid to another charged amino acid 
(chargedcharged) is an interesting case. The mutation could preserve the charge (Asp 
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 Glu; Lys  Arg) or invert the charge (Asp,Glu  Lys, Arg). Presumably, a mutation 
that preserves the charge should have a lesser effect on the binding energy as compared 
with charge-reversal mutations. However, our analysis showed that this is not always the 
case. Overall, all mutations of the target charged residue to another charged residue were 
found to be unfavorable events (Table 5.1). Even in the case of Glu to Asp substitutions, 
like aldolase B (s2525, Glu to Asp in position 64), which is a mutation (refSNP ID: 
2854709) that preserves the net charge of the complex, the change of the binding energy 
is huge: ∆∆∆Gtot(nsSNP) = -9.06 kcal/mol, ∆∆∆Gvdw(nsSNP ) = -1.58 kcal/mol and 
∆∆∆Gel(nsSNP) = -11.30 kcal/mol. This is due to the fact that the side chain of Asp is 
shorter than the Glu side chain, and the nsSNP introduced Asp cannot form a strong salt 
bridge with the original partner Lys in position 270 of the other chain in this homo-dimer 
complex. Another example (Figure 5.2b) is the case of charge reversal in Roadblock-1 
(DYNLRB1), which is a homo-dimeric protein that may be involved in tumor 
progression, as the up-regulation of this gene is as ociated with hepatocellular 
carcinomas. The corresponding nsSNP (refSNP ID: rs11537531) of this protein results in 
the change of a Lys amino acid to a Glu amino acid t the complex’s interface. In the 
target protein complex, the distance between Lys75 from chain A and its partner Asp61 
from chain D is only 1.62 Å, resulting in a very strong hydrogen bond and pair-wise 
electrostatic interactions.  However, in the nsSNP variant, the positively charged Lys is 
replaced by Glu, a negatively charged residue. Due to minimization, the distance between 
the nsSNP residue and the original Asp61 from chain D i creases to 9.99Å due to the 
repulsive charge-charge interaction between the two negatively charged groups (Figure 
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5.2b). This reduces the effect, but the binding energy is still much less favorable as 
compared with the dominant allele. The corresponding energy changes are 
∆∆∆Gtot(nsSNP) = -11.13 kcal/mol, ∆∆∆Gvdw(nsSNP) = -4.42 kcal/mol and 
∆∆∆Gel(nsSNP) = -3.08 kcal/mol. This is an example of a structural relaxation that 
reduces the effects of charge reversal.  
 
Binding energy changes caused by a substitution of a small amino acid 
 There are 94 cases in our dataset for which a small residue located at the interface 
of the target protein-protein complex is substituted into the nsSNP variant (Table 1). 
Overall, the total binding energy and electrostatic components are statistically significant 
(both P-values are 0.002) shifted toward negative values which indicates that nsSNP 
destabilizes the complex.  
 Substitution of a small with another amino acid almost always will result in 
sterical clashes. The volume of a small amino acid is much smaller that the volume of the 
other residues. Thus, there will be no room for bulky amino acid side chain at the 
interface. Such a replacement will cause distortion of the interface and will weaken the 
binding (Table 5.1). A typical example is the histidine triad nucleotide binding protein 1 
(HINT1), Gene ID: 4885413. The nsSNP codes for Gly to Arg substitution in position 92 
of B chain. The substitution introduces a new charged residue, which pays large 
desolvation penalty and the resulting change in the electrostatic component of the binding 
energy ∆∆∆Gel(nsSNP) is -9.23 kcal/mol).  
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 However, there are also opposite examples, indicating that protein complexes can 
tolerate small amino acid substitutions at the interfaces. A typical example is Human β-
globin (HBB), which regulates developmental expression. The corresponding nsSNP 
(refSNP ID: rs1141387) in this protein replaces a Val residue with a Leu amino acid.  
Despite the difference in these two amino acids’ volumes, the structure of the complex 
does not change by much, resulting in very small energy differences: ∆∆∆Gtot(nsSNP) = -
0.16 kcal/mol ∆∆∆Gvdw(nsSNP) = -0.44 kcal/mol and ∆∆∆Gel(nsSNP) = -0.00 kcal/mol 
(Figure 5.2c). The main reason for this is that both side chains are partially exposed to the 
solution, and there is room for a larger Leu side chain. 
 
Binding energy changes caused by a substitution of a hydrophobic amino acid 
 There are 32 cases in our dataset in which a hydrophobic residue located at the 
interface of the target protein-protein complex is substituted by the nsSNP variant (Table 
1). The mean values of all energy distributions are not significantly different from zero. 
In general, substituting a hydrophobic residue at the interface with another residue does 
not have large effect on protein-protein binding. Perhaps this is due to the fact that 
hydrophobic groups do not form specific interactions. Thus, the effect of a replacement 
of a particular hydrophobic side chain with another residue depends on geometry of the 
interface and the ability of the substituted side chain to form new interactions.  For 
example, a polar or charged residue, substituting a hydrophobic one, could increase the 
binding affinity only if the corresponding residue manages to create new favorable 
interactions across the interface. If this does not occur, then the mutation should weaken 
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the binding. Such a case is shown in Figure. 2d. Glutathione S-transferase M2 (GSTM2) 
is an important enzyme that contributes to the metabolism of phase II biotransformation 
of xenobiotics. The corresponding nsSNP (refSNP ID: rs1056799) changes the target 
amino acid Met to Lys in position A130. However, the new charged residue cannot form 
favorable interactions with any other residue across the interface since it is in a 
hydrophobic environment. As a result, the solvation loss cannot be compensated for, and 
the mutation weakens the binding.  
 
Correlation of the calculated effect on the binding affinity and residue conservation 
 Multiple sequence alignments (MSA) were used for phylogenetic analysis and for 
determining the evolutionary relationships between different species. Only positions 
corresponding to interfacial sites were considered. A position in the MSA that is totally 
or highly conserved indicates strong evolutionary constraints, and the substitution of such 
a highly-conserved amino acid is expected to have significant effects on protein structure, 
function and interactions. In contrast, an amino acid that is not conserved among different 
species is, perhaps, not crucial for the structure, function and interactions of that 
particular protein complex.  
 We began our analysis with a case corresponding to a highly conserved site. 
Position B34 in Human β-globin (HBB) is totally conserved among the species (Figure 
5.3a). The nsSNP causes a mutation that changes Val residue to Leu. As result, the total 
binding energy, van der Waals and electrostatic components are more favorable in the 
target complex compared with the nsSNP variant. Thecorresponding changes of the 
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binding energy are ∆∆∆Gtot(nsSNP) = -0.94 kcal/mol, ∆∆∆Gvdw(nsSNP) = -0.10 kcal/mol 
and ∆∆∆Gel(nsSNP) = -1.12 kcal/mol. 
 Another example is GSTM2, glutathione S-transferas M2 (Figure 5.3b). Position 
A130 is not conserved; in humans it is a Met residue, however, in other species the same 
position is a Lys amino acid. The nsSNP induces a Met  Lys change in the human 
protein, a mutation that is already seen in other sp cies. Perhaps this explains why such a 
drastic change (a hydrophobic to a charged group) has little effect on the binding affinity. 
The corresponding changes of the binding energy are ∆∆∆Gtot(nsSNP) = -0.53 kcal/mol, 
∆∆∆Gvdw(nsSNP) = 0.28 kcal/mol and ∆∆∆Gel(nsSNP) = -0.26 kcal/mol.  
 
 
Figure 5.3: Multiple sequence alignment (MSA). The blank frame is nsSNP position. (a) 




 The magnitude of the binding energy change as a function of the degree of 
conservation is shown in Figure 5.4. It can be seen that as the degree of conservation 
increases (calculated in terms of percent identity, SI%) the maximal amplitude of both the 
∆∆∆Gtot(nsSNP) and the ∆∆∆Gel(nsSNP) increases as well (illustrated by the broken lines 
in Figure 5.4). The effect culminates at high SI% (SI% > 80%) where the variance of the 
magnitude of both the ∆∆∆Gtot(nsSNP) and the ∆∆∆Gel(nsSNP) is significantly different, 
i.e. the null hypothesis about the equality of variances between the bins was rejected with 
P-value<0.00001 (see Methods section). Note that this corresponds to significant variance 
of the binding constant resulting to either increase/decrease or no change of the affinity. 
The points located close to the horizontal axis andcorresponding to highly conserved 
positions (Figure 5.4) indicate that in some cases, a mutation of a highly conserved amino 
acid may not affect the binding affinity. In these cases, the effect depends on the 
geometry of the interface and where the site is situated. These highly conserved sites are 
predominantly located at the periphery of the binding interface and apparently are not 
important for the binding affinity. Figure 5.4 provides indirect support demonstrating that 
the calculated effects are reasonable, since no large binding energy change was calculated 





Figure. 5.4: The change of the binding energy as a function of the amino acid 
conservation (SI%). The broken lines are guides for the eye and follow the maximal 
amplitude of binding energy change). (a) ∆∆∆Gtot(nsSNP). (b) ∆∆∆Gel(nsSNP)  
 
 
Effect of nsSNPs on proton uptake/release 
  Figure 5.5 shows the change of the corresponding binding energy as a function of 
the absolute difference of the proton uptake/releas for target complexes and an nsSNP 
variant calculated at pH = 7.0. No correlation between either the magnitude or variance of 
the binding energy change and ∆∆q was found. At the same time, it can be seen that most 
∆∆q are close to zero, indicating that at least around a pH of 7.0 the pH-dependences of 
the binding energy are the same for the target complex and the nsSNP variant. However, 
this is not necessarily the case for the entire pH-dependence. At the same time, there is 
significant percentage of cases in which the ∆∆q is different from zero. This indicates 
that nsSNP mutations not only change the binding energy but also result in a different 
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pH-dependence of the binding. This could have a significant physiological importance; 
however, there is practically no experimental data av ilable for comparison.  
 
 
Figure 5.5: The change of the binding energy as a function of calculated proton  
uptake/release (absolute value of ∆∆q). (a) ∆∆∆Gtot(nsSNP). (b) ∆∆∆Gel(nsSNP)  
  
 In general any substitution can lead to ionization changes. The above results indicate 
that an amino acid substitutions corresponding to nsSNPs not only change the binding 
energy but could also result in changes in the ionization states of the titratable groups. 
Such an effect could occur not only when a titratable group is involved in the target 
nsSNP mutation but could also occur in each of the ot r cases as well. This is because 
any substitution changes the geometry of the interfac  and thus affects the electrostatic 
potential of all ionizable residues. However, in this study we did not perform charge 
relaxation, i.e., no attempt was made to adjust the residues’ ionization states according to 
the pKa calculations because the calculated proton uptake/release is a fractional number. 
Modeling fractional ionization in single point calcu ations is impossible and any attempt 
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would be an error (see for details [61]). However, a more sophisticated approach 
involving ensemble presentation could take into account these ionization changes and 
will result in a reduction of the magnitude of the energy change caused by the nsSNP 
mutation. Thus, all of the data points (Figure. 5.5) corresponding to ∆∆q that are 
significantly different from zero may get closer to ∆∆∆G (nsSNP) = 0, i.e., closer to the 
horizontal axis. Perhaps this is an effect that occurs in vivo and results in toleration of 
nsSNP mutations. Site-directed mutagenesis experiments and complementary numerical 
calculations have proven the charge-compensatory effect [62-64]. Perhaps, the charge-
compensatory is the reason that maximal ∆∆q (Figure. 5.5) is only about 0.6 units, 
despite that some nsSNPs cause charge reversal.  
 
CONCLUSION 
 This analysis is focused on nsSNPs located at protein-protein interfaces. Protein-
protein interactions are essential for cell function, and nsSNPs affecting these interactions 
are expected to have significant impacts on the protein interaction network. Indeed, our 
analysis showed that OMIM and some non-OMIM nsSNP might have a significant effect 
on binding energy especially on the electrostatic component. Although the effect is 
statistically significant, the majority of amino acid substitution corresponding to nsSNP 
does not affect the binding affinity by much. This observation should be taken with 
caution. A small change of the binding affinity by a kcal/mol or even less could still 
disrupt the functionality of the interaction network or change the kinetics of the 
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corresponding reaction [24, 25]. However, investigating this effect requires modeling 
protein-protein networks, a task that is far beyond the goals of the present study. 
  Two data sets were considered in this study: nsSNPs that are known to be disease-
causing (OMIM dataset) and nsSNPs that were not annot ted to be disease-causing (non-
OMIM). The distributions of the change in the bindig energy and its components in both 
the OMIM and non-OMIM cases were found to be different although the difference is 
small. However, looking at the electrostatic component of the free energy we found that it 
is significantly shifted toward negative values forOMIM nsSNP, this is not the case for 
non-OMIM nsSNPs.  This indicates that disease-causing nsSNPs tend to destabilize 
electrostatic component of protein binding energy, in contrast with non-OMIM nsSNPs.  
  Although large number of nsSNPs did not affect protein interactions by much 
(perhaps this shows the plasticity of protein interfaces and their ability to tolerate amino 
acid changes), an even larger fraction of the nsSNPs did affect the affinity. In fact, about 
a half of nsSNPs destabilize/stabilize the complexes by more than 1kcal/mol. In addition, 
we find that 31.8% of nsSNPs affect protein-protein binding by more than 2kcal/mol and 
23.9% by more than 3kcal/mol.  
  As was mentioned before, in the case of non-OMIM complexes there is no 
information about which nsSNP is the dominant allele. However, our numerical protocol 
builds a 3D model of the first allele in the list, minimizes the structure and then 
introduces a side chain mutation at the nsSNP position and minimizes the mutant 
structure. Could this bias the calculations? Since ∆∆∆G(nsSNP) is a difference between 
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two binding energies, the change of the order will simply change the sign of the 
∆∆∆G(nsSNP). If the numerical protocol is not biased, then we should see that the effect 
of, for example, a PC mutation is opposite to the effect of a CP variation. Comparing 
the means reported in the supplementary results, Table D.1, we can see that this is the 
case, except for CH and HC. (in both cases the means of the distributions of 
∆∆∆Gtot(nsSNP) were found to be negative). However, this is the smallest subset in our 
study comprised of only 5 cases and many more examples are needed to draw a 
conclusion.  
  Another important issue to address is how sensitive the results are in respect to the 
computational protocol and force field used. Recently we have demonstrated that the 
calculations of absolute value of the binding energy are very sensitive to both 
computational protocol and force fields [65]. The same study [65], however, found that 
the distribution of the binding energy and the general trends are almost insensitive to 
force field and protocol used. Since the present study is not aimed at computing the 
absolute binding energy, but rather the change of the binding energy upon single amino 
acid substitution, the effects of force field and computational algorithm are expected to 
largely cancel out.      
  It is expected that a mutation that changes the physico-chemical property of a 
position at the interface of the corresponding protein-protein complex should affect 
binding affinity. However, our results indicate that this is not necessarily the case. The 
outcome of the mutation depends on a variety of factors, whose interplay determines the 
effects of the substitution. In addition, some positi ns are located in structural regions 
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that allow for structural relaxations. From an energetics perspective, an amino acid 
substitution may not always affect the binding affinity. An example includes a charged 
residue for which the favorable pair-wise interactions are almost entirely cancelled by an 
unfavorable desolvation penalty. Another example is weak hydrogen bonds formed at the 
interface. A third example is a partially exposed hy rophobic residue at the periphery of 
the interface. Substitution of such residues with another may not affect the binding 
affinity; in fact, the nsSNP mutation could strengthen the binding. 
  A highly conserved position within the protein sequ nce is often related to an 
important biological function. Multiple sequence alignment analysis showed that most of 
the positions corresponding to interfacial nsSNPs in our dataset are highly conserved. It 
was shown that the variance of the total binding energy and its components of the highly 
conserved positions is larger as compared with the variance of positions with lower 
conservation. However, significant fraction of nsSNP occurring at conserved positions 
was calculated not to change the binding energy by much. This indicates that 
conservation of amino acids in certain interface positions does not occur to preserve 
binding affinity. Rather, such conservation may reflect the preservation of the binding 
mode or specificity. An interesting case is an nsSNP mutation that introduces an amino 
acid found in another species. Since such a mutation was evolutionarily accepted in the 
other species, the overall effect on protein-protein affinity is expected to be small. In 
further work, we will explore this observation and will determine the effects of 
introducing mutations to any other 20 amino acids. 
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  In this paper, we showed that that the change of the binding energy from the 
target complex to the nsSNP variant is not related to the conservation of the net charge, 
hydrophobicity or hydrogen bond network. This implies that one cannot simply use the 
physical-chemical properties of amino acids to evaluate the effects an nsSNP has on 
protein-protein interactions. Rather detailed structure-based energy calculations must be 
performed in order to predict these effects, as it was done in the present work.  
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STRUCTURAL ASSESSMENT OF THE EFFECTS OF AMINO ACID 




A structure-based approach is described for predicting the effects of amino acid 
substitutions on protein function. Structures were pr dicted using a homology modelling 
method. Folding and binding energy differences betwe n wild-type and mutant structures 
were computed to quantitatively assess the effects of amino acid substitutions on protein 
stability and protein–protein interaction, respectively. We demonstrated that pathogenic 
mutations at the interaction interface could affect binding energy and destabilise protein 
complex, whereas mutations at the non-interface might reduce folding energy and 
destabilise monomer structure. The results suggest that the structure-based analysis can 
provide useful information for understanding the molecular mechanisms of diseases. 
 
INTRODUCTION 
Revealing the effects of amino acid substitutions o protein structure and function 
is critical for understanding the complex mechanisms of human disease caused by single 
amino acid mutations. There are 67,000 - 200,000 non-synonymous Single Nucleotide 
Polymorphisms (nsSNPs) in the human population [1], which give rise to a large number 
of amino acid substitutions in proteins. The residue changes at key sites within a protein 
                                                  
5Teng S, Srivastava AK, Schwartz CE, Alexov E, Wang L: Structural assessment of the effects of 
amino acid Substitutions on protein stability and protein-protein interaction, Int. J. Computational Biology 
and Drug Design 2010, 3(4):334-349. 
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may result in a series of conformation changes, including the breakage of salt bridges, 
alteration of interaction network, disruption of hydrogen bonds, which in turn may 
perturb the energy landscape. These changes can affect the kinetics of protein folding or 
cause protein aggregation and destabilisation [2]. More than half of monogenic diseases 
are caused by single mutations, and a common mechanism by which amino acid 
substitutions cause human disease is protein stability change. Yue and Moult investigated 
the effect of amino acid substitutions on protein stability, and estimated that 
approximately 25% of nsSNPs in the human population might be deleterious to protein 
function [3]. Of the known disease-causing missense mutations, the majority (83%) 
resulted in alternation of protein stability [4].  
Amino acid substitutions can also affect protein-protein interactions. 
Approximately 88% of disease-associated nsSNPs are found to be located in the 
voids/pockets important for protein-protein interactions [5]. The amino acid substitutions 
located at the binding interface or active site cleft could block the entrance to the active 
site, change the recognition, alter the specificity, or affect the binding affinity. For 
example, the substitution G2019S in leucine-rich repeat kinase 2 (LRRK2) was shown to 
be associated with familial and sporadic Parkinson's disease [6]. Structure analysis 
indicates that this mutation is located at the interface of LRRK2’s N-terminal and C-
terminal domains which is important for positioning of Mg2+ within the active site of the 
kinase [7, 8]. This finding is in agreement with the experimental result that G2019S 
enhances kinase activity in vitro [9]. Recently, Teng et al. [10] examined the effects of 
nsSNPs at the interaction interfaces of 264 protein complexes using a homology 
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modeling method and all atoms energy calculations. The results suggest that disease-
causing mutations tend to destabilise protein-protein interactions. Therefore, 
understanding how amino acid substitutions affect protein stability and protein-protein 
interactions can provide new insights into the molecular mechanisms of human genetic 
diseases. 
Protein structure modeling methods have been widely used for predicting the 
effects of disease-causing mutations on protein stability and protein-protein interaction. 
For instance, to predict the effects of the mutations related to the genetic disorder 
galactosemia, more than one hundred mutant structures of galactose-1-phosphate 
uridyltransferase were constructed using the homology modeling method, and the results 
suggested that most mutations might alter protein stability [11]. By mapping disease-
causing mutations onto known three-dimensional protein structures, Dimmic and 
coworkers [12] have shown that about 70% of the delterious mutations are located in the 
structurally and/or functionally important sites. However, the effects of mutations were 
analyzed statically in these studies. The free energy perturbation (FEP) calculation has 
been used to quantitatively assess the effects of amino acid substitutions on protein 
stability. Dixit et al. [13] used the AMBER force field and solvent-accessible surface area 
solvation methods to calculate the protein stability changes in terms of free energy 
differences caused by cancer-associated mutations in the RET and MET kinases, and 
showed that the amino acid substitutions could decrease the thermodynamical stability of 
the mutant structures. The FEP calculation was also used to assess the protein stability 
changes upon single amino acid substitutions in membrane proteins [14]. Nevertheless, 
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these studies on FEP calculation did not take into account the effects of amino acid 
substitutions on protein-protein interactions. 
The advent of high-throughput sequencing technology makes it possible to 
identify a large number of nsSNPs in the human genome. The dbSNP database, one of 
the primary data resources for genetic studies, contains the information of more than 23 
million human SNPs [15]. The records in the dbSNP database are linked to the Online 
Mendelian Inheritance in Man (OMIM) database, which ontains disease gene 
information, including genetic polymorphisms, map locations, inheritance patterns and 
clinical descriptions [16]. Computational analyses provide an efficient way for examining 
the effects of nsSNPs on protein stability and functio , and for identifying potential 
disease-causing mutations. Ng and Henikoff [17] used a position-specific scoring matrix 
(PSSM) based method called Sorting Intolerant From T lerant (SIFT) to predict whether 
an amino acid substitution affects protein function. We have recently developed the 
MuStab web server for predicting protein stability changes upon amino acid substitutions 
from sequence features [18]. MuStab uses a support vector machine (SVM) model to 
discriminate between destabilizing and stabilizing amino acid substitutions in proteins. 
iPTREE-STAB [19] and I-Mutant 3.0 sequence version [20] are also available for 
sequence-based prediction of protein stability changes caused by point mutations. 
Structure-based methods, including PoPMuSiC-2.0 [21], Dmutant [22], Eris [23], I-
Mutant 3.0 structure version [20] and FoldX [24], are vailable for examining the effects 
of mutations on protein stability and protein-protein interactions. In particular, the FoldX 
software tool can be used to provide quantitative estimations about the effects of amino 
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acid substitutions on the stability of proteins or protein complexes using the empirical 
force field calculation [24]. Among these protein stability predictors, I-Mutant3.0 
structure version, Dmutant and FoldX gave the best predictive performances [25].  
The experimental approach for determining the effects of amino acid substitutions 
on protein stability is to obtain the mutant proteins and measure their thermal stability 
changes by melting experiments. However, the experimental approach is time-consuming 
and thus may not be applied to a large number of amino acid substitutions. In the present 
study, a structure-based approach was performed for predicting the effects of amino acid 
substitutions on protein stability and protein-protein interaction. The differences of 
folding energy and binding energy between the wild-type and mutant structures were 
calculated to predict the protein stability and protein-protein interaction changes caused 
by the mutations. The predictions were evaluated by using other bioinformatic methods. 
The results suggest that the structure-based approach can provide useful information for 
characterizing disease-causing mutations in human genetic studies. 
 
METHODS 
The schematic diagram of the structure-based approach is shown in Figure 6.1. 
The methodology was also investigated in two previous studies [26, 27]. For a specific 
gene with mutations, the related sequence and disease information were extracted from 
the dbSNP and OMIM databases. If the structure of the target protein was available in the 
Protein Data Bank (PDB), no structure modeling was needed. Otherwise, target structures 
were constructed using the homology modeling method [28]. The suitable templates were 
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identified in the PDB database using the PSI-BLAST program [29], and then used to 
construct the target structures with the NEST program [30]. Energy minimization was 
performed to obtain the optimal structure with the TINKER program [31], and the mutant 
structure was constructed using the SCAP program [32]. The folding energy of the wild-
type or mutant structure was calculated using TINKER to estimate the effects of the 
mutations on protein stability. For amino acid substitutions located at the interface, the 
binding energy changes were also computed to predict the effects of the mutations on 
protein-protein interaction. At the end, the predictions were compared with several 
bioinformatics tools, including FoldX [24], PoPMuSiC-2.0 [21], Dmutant [22], Eris [23], 




Figure 6.1 Schematic diagram of the approach for assessing the effects of amino acid 
substitutions on protein stability and protein-protein interaction. Underlined are the 
software tools used in this study. 
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Protein structure modeling 
Homology modeling was applied to the proteins with no structures available in the PDB 
database. The structures were modeled as follows:  
1) Template searching: The suitable templates were s l cted from the PDB database for 
the target protein. Position-Specific Iterated BLAST (PSI-BLAST) [29] was used for the 
template searching. The structures with significant E-value (< 10-5) were selected as the 
suitable templates. 
2) Structure building:  The program NEST was used to the build structure models 
according to the sequence alignment between the targ t p otein and its structural template 
[30]. NEST is an integrated model-building program, including the program LOOPY9 for 
loop prediction and SCAP10 for side-chain modeling.  
3) Energy minimization:  To generate the optimal structure, energy minimization was 
performed by using the TINKER package [31] with the CHARMM27 force field 
parameters [33]. The MINIMIZE program in TINKER was u ed to minimize structures 
with the algorithm of Limited Memory BFGS Quasi-Newton Optimization [31].  
 The mutant structures were derived in silico from the wild-type structure using the 
SCAP program [32]. The amino acid substitutions were introduced by side-chain 
replacements with the rest of the structure kept rigid. The MINIMIZE program in the 





Folding energy calculation 
The effects of amino acid substitutions on protein stability were assessed by the 
folding energy changes. The energy calculation was based on the monomer structure of 
the target protein, and was performed as described in the recent publication [27]. The 
folding energy is the energy difference between the folded and unfolded states: 
    )()()( unfoldedGfoldedGfoldingG −=∆                                     (6.1) 
where G(folded) or G(unfolded) is the total potential energy of the target protein in the 
folded or unfolded state, respectively.  
The protein stability change (∆∆Gstability) is the folding energy difference between 
the wild-type (WT) structure and the structure with the amino acid substitution (AAS). It 







∆−∆=∆∆  (6.2) 
However, the energy difference between the wild-type and mutant proteins in the 
unfolded state, G(unfolded: WT) - G(unfolded: AAS), is difficult to calculate. In the 
present study, we assume that the difference of energy in the unfolded state can be 
estimated by using the substitution site and its neighboring residues. The total potential 
energy of the eleven-residue segment (S11) with the substitution site in the middle 
position was used to represent the folding energy of the full-length protein in the 
unfolded state. Equation (2) can thus be rewritten as: 
)]:():([)]:():([ 1111 ssstability AASfoldedGWTfoldedGAASfoldedGWTfoldedGG −−−=∆∆  (6.3) 
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All of the above total potential energy terms were calculated using the 
ANALYZE program in the TINKER package. A positive value of ∆∆Gstability indicates 
that the amino acid substitution may make the protein more stable, whereas a negative 
value of ∆∆Gstability suggests that the mutation can destabilise the prot in. 
 
Binding energy calculation 
For an amino acid substitution located at the interaction interface, the binding 
energy difference of the protein complex between the wild-type and mutant structures 
was used to assess the effect of the mutation on protein-protein interaction. As described 
in the previous study [10], the binding energy was calculated using the rigid body 
approach, in which the structures of the monomers were kept as they were in the dimer 
complex. The binding energy, ∆∆G(binding), was the difference between the total 
potential energy of the dimer complex and the individual monomers: 
):():():()( BfoldingGAfoldingGcomplexfoldingGbindingG ∆−∆−∆=∆∆ (6.4) 
where ∆G(folding: complex), ∆G(folding: A) and ∆G(folding: B) are the folding free 
energy values of the dimer complex, monomer A and monomer B, respectively. Since the 
internal mechanical energy values of the unbound and bound monomers are the same, the 
energy terms in the unfolded state can be canceled out in equation (4). Thus, the binding 
free energy can be calculated as below: 
):():():()( BfoldedGAfoldedGcomplexfoldedGbindingG −−=∆∆   (6.5) 
where G(folded: complex), G(folded) and G(folded) are the total potential energy values 
of the dimer complex, monomer A and monomer B in the folded state, respectively.  
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In this study, the total potential energy was computed using the ANALYZE 
program in the TINKER package. The effect of an amino acid substitution on protein-
protein interaction was assessed by using the binding energy difference between the wild-
type (WT) structure and the structure with the amino acid substitution (AAS): 
):():( )G( AASbindingGWTbindingGbinding ∆∆−∆∆=∆∆∆    (6.6) 
A positive value of the binding energy change (∆∆∆Gbinding) indicates that the amino acid 
substitution may strengthen the binding affinity and make the protein dimer complex 
more stable. In contrast, a negative value of ∆∆∆Gbinding suggests that the mutation can 
weaken the binding affinity and destabilise the dimer complex. 
 
Prediction evaluation 
Several bioinformatic tools were used to evaluate th  predictive power of the 
structure-based approach used in this study, and the predictions were considered to be 
reliable if a consensus was reached by most of the predictors. Sequence-based prediction 
of the direction of protein stability change could give useful information. Three 
sequence-based tools were used to predict the directions of protein stability changes 
caused by amino acid substitutions from primary sequence data, including iPTREE-
STAB (http://210.60.98.19/IPTREEr/iptree.htm), MuStab 
(http://bioinfo.ggc.org/mustab/) and I-Mutant3.0 (sequence version) 
(http://gpcr2.biocomp.unibo.it/cgi/predictors/I-Mutant3.0/I-Mutant3.0.cgi). 
Structure-based prediction methods could provide quantitative assessment of the 
effects of amino acid substitutions on protein stabili y. Khan and Vihinen [25] compared 
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the predictive performances of different protein stability predictors, and showed that three 
structure-based tools, including I-Mutant3.0 (structure version) 
(http://gpcr2.biocomp.unibo.it/cgi/predictors/I-Mutant3.0/I-Mutant3.0.cgi), Dmutant 
(http://sparks.informatics.iupui.edu/hzhou/mutation.html) and FoldX [24] were the most 
reliable predictors. These three tools were used in this study. Other two structure-based 
predictors, including PoPMuSiC-2.0 (http://babylone.ulb.ac.be/popmusic/) and Eris 
(http://eris.dokhlab.org), were also used to calculte the folding energy for monomer 
structures, respectively. The difference of the folding energy between the wild-type and 
mutant structures was used to assess the protein stability change caused by an amino acid 
substitution, and compared with the ∆∆Gstability value calculated using the approach 
applied in this paper. Furthermore, FoldX was also u ed to determine the interaction 
energy of complex protein. The effect of an amino acid substitution on protein-protein 
interaction was estimated by the interaction energy difference of the protein complex 
between the wild-type and mutant structures (∆∆∆GFoldX), which was compared with 
∆∆∆Gbinding computed using the method utilized in this study. 
In addition, ClustalX [34] was used to perform the multiple sequence alignment 
for conservation analysis. Protein sequences from different species were downloaded 






RESULTS AND DISCUSSION 
To evaluate the usefulness of the structure-based appro ch utilized in this paper, 
three case studies were carried out for four pathogenic mutations and one neutral nsSNP 
in three human genes (Table 6.1). One disease-causing mutation, A111V (dbSNP ID: 
rs28928889, OMIM ID: 141850.0029), and one neutral nsSNP, T119N (dbSNP ID: 
rs1058069), in the human HBA2 gene (haemoglobin subunit alpha) were used to show 
their different effects on protein stability and protein-protein interaction. Two pathogenic 
mutations, Q61K (dbSNP ID: rs28933406, OMIM ID: 19002 .0002) and A146T (dbSNP 
ID: rs104894231, OMIM ID: 190020.0008), in the human HRAS gene (v-Ha-ras Harvey 
rat sarcoma viral oncogene homolog) were analyzed to assess the effects of mutations on 
different structural regions (interface or non-interface). The computational approach was 
also used to investigate the substitution, A693V, in the human ZBTB20 gene (zinc finger 
and BTB domain containing 20). As discussed in the following sections, the results 
suggest that the pathogenic mutations make the monoer structures less stable 
(∆∆Gstability < 0), and/or weaken the binding affinity to destabilise the dimer structures 
(∆∆∆Gbinding < 0). In contrast, the neutral nsSNP has only slight effects on protein 
stability and protein-protein interaction (∆∆Gstability and ∆∆∆Gbinding close to 0).  
It was shown that the predictions agree well with the results gave by the most of 
structure-based methods. However, the sequence-based tools often did not agree with the 
consensus predictions from the structure-based methods (Table 6.1). The structure-based 
predictors (I-Mutant3.0 structure version, Dmutant d FoldX) appeared to be more 
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reliable for predicting protein stability changes caused by mutations [25]. Thus, this study 
focused on the structure-based analyses.  
 
Table 6.1 The effects of five amino acid substitutions on protein stability. The unit of 
energy change is kcal/mol. 













∆∆Gstability -0.75 0.06 -4.42 -1.39 -2.69 
FoldX -4.19 10.54 -2.74 -0.22 -0.68 
PoPMuSiC-
2.0 
-0.49 -0.50 -0.24 -0.38 -0.05 
Dmutant -0.48 0.32 -0.38 -0.24 -0.34 




0.13 -0.30     0.29     -0.79 -0.03 







Increased Increased Increased Decreased Increased 
MuStab Increased Decreased Increased Decreased Increased 
iPTREE-
STAB 
Increased Decreased Increased Decreased Decreased 
Consensus Increased Decreased Increased Decreased Increased 
 
Pathogenic mutation and neutral nsSNP in haemoglobin 
Haemoglobin molecules in red blood cells transport oxygen from the lung to the 
peripheral tissues, and thus are important for maintaining cell viability. Human 
haemoglobin is made up of symmetric dimers of polypeptide chains, the α/β-globin 
dimers [35]. Several point mutations in α-globin have been shown to cause α-thalassemia, 
which can result in Hydrops fetalis [36]. In this study, the two amino acid substitutions of 
human haemoglobin subunit alpha (HBA2), A111V and T119N, were analyzed to show 
the different effects of disease-causing and neutral amino acid substitutions on protein 
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stability and protein-protein interaction. The homodimer structure of HBA2 was built 
using the crystal structure of human deoxy haemoglobin (PDB: 1O1P) as the template. 
The majority of disease-causing mutations cause protein destabilisation, whereas 
most neutral nsSNPs have limited effect on protein stability [4]. In the present study, the 
predicted effects of A111V (disease-causing) and T119N (neutral) on protein stability 
agree well with the previous observations. As shown in Table 6.1, the folding energy 
change (∆∆Gstability) caused by A111V is -0.75 kcal/mol, suggesting that e mutation 
may destabilise haemoglobin monomer structure. The decreased protein stability is also 
predicted for the A111V mutation by three structure-based tools including FoldX, 
PoPMuSiC-2.0 and Dmutant (Table 6.1). In contrast, the neutral nsSNP (T119N) is 
predicted by our calculations and three structure-based tools (FoldX, Dmutant and Eris) 
to stabilize the protein monomer. PoPMuSiC-2.0 and I-Mutant3.0 (structure version) give 
the opposite predictions. The results suggest that T119N may not cause destabilisation of 
the monomer structure. 
Amino acid substitutions at the interaction interface may result in binding affinity 
changes, and thus affect the structure of the protein complex. As shown in Figure 6.2a, 
the pathogenic mutation, A111V, is located in the α-helix of the HBA2 binding interface. 
Although most regions of the wild-type and mutant structures are similar, the structures 
are not overlapped in the α-helix interface region. This structural change may 
significantly affect the binding energy, and make th  protein complex unstable. The 
observation has been confirmed by the binding energy calculation using both TINKER 
and FoldX (∆∆∆Gbinding = -11.56 kcal/mol and ∆∆∆GFoldX = -1.41 kcal/mol) (Table 6.2). 
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In contrast, the neutral nsSNP (T119N) is located in the flexible loop region (Figure 
6.2b). Since T119N is not located in the inner region of the interface, it may not 
significantly affect protein-protein interaction. The binding energy change caused by 
T119N is ∆∆∆Gbinding = 0.90 kcal/mol (Table 6.2), which is smaller than the absolute 
value of binding energy change caused by A111V. 
In addition, the multiple sequence alignment shown in Figure 6.2c suggests that 
the residue, Ala 111, is well conserved, but Thr 119 is not conserved in Xenopus laevis 
and Xenopus tropicalis. The result agrees with the previous observation that pathogenic 







Figure 6.1 Illustration of two amino acid substitutions (A111V and T119N) in human 
HBA2. a) Structural representation of the A111V mutation. The wild-type chain A is 
shown in green color, mutant chain A in cyan, wild-type chain B in yellow, and mutant 
chain B in orange. The amino acid residue Ala 110 (wild-type) is shown in magenta, and 
Val 110 (mutant) in white. b) Structural representation of T119N. Chains A and B are 
shown in green and yellow, respectively. The residue Asn 119 (wild-type) is shown in 
pink, and Thr 119 (mutant) in blue. c) Multiple sequ nce alignment of HBA2 with the 
amino acid substitution sites indicated. 
 
 
Table 6.2 The effects of five amino acid substitutions on protein-protein interaction. The 













∆∆∆Gbinding -11.56 0.90 -7.29 -0.21 -0.31 






Pathogenic mutations at the interface or non-interface of HRAS 
Follicular carcinoma is the second most common thyroid cancer, which accounts 
for about 15% of all thyroid malignancies. The v-Haras Harvey rat sarcoma viral 
oncogene homolog (HRAS) encodes a follicular cancer-related protein located at the inner 
surface of cell membrane. The protein plays an important role in the transduction of 
signals arising from tyrosine kinase and G protein-coupled receptors. One pathogenic 
mutation (Q61K) in HRAS was found to cause constitutive activation of the downstream 
signaling pathways [38]. Another disease-causing mutation (A146T) was identified in 
patients with Costello syndrome, and was shown to affect the GTP/GDP binding of 
HRAS [39]. In this study, the heterodimer structure of HRAS has been built using the 
crystal structure of the transforming protein RhoA (PDB: 1OW3) as the template. The 
amino acid substitution Q61K is located at the interaction interface (Figure 6.3a), and 
A146T lies in a non-interface region of HRAS (Figure 6.3b). These two mutations in 
different structural regions have been analyzed to assess their effects on protein stability 
and protein-protein interaction. 
Both amino acid residues in the HRAS protein, Gln 61 and Ala 146, are 
conserved in other species (Figure 6.3c), suggesting that they may be functionally 
important sites. As shown in Table 6.1, the folding energy changes (∆∆Gstability) caused by 
Q61K and A146T are -4.42 kcal/mol and -1.39 kcal/mo (Table 6.1), respectively, 
suggesting that both mutations may destabilise the HRAS monomer structure. Consistent 
with the above results, the predictions made by structu e-based tools show decreased 
protein stability for both mutations (excluding I-Mutant3.0 structure version for Q61K). 
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Furthermore, all the sequence-based methods also predict that A146T could make HRAS 
protein unstable.  
The Q61K mutation is located at the interaction interface (Figure 6.3a), and the 
binding energy change caused by Q61K is ∆∆∆Gbinding = -7.29 kcal/mol, or ∆∆∆GFoldX = -
2.40 kcal/mol (Table 6.1), suggesting that the mutation may significantly affect protein-
protein interaction. The distance between Gln 61 and its interaction partner, Arg 47 from 
the other chain, is only 1.88 Å, which is within the distance of hydrogen bond formation. 
When the polar residue Gln is replaced by positively charged residue Lys, the hydrogen 
bonds may be affected, and thus make strongly unfavorable interactions with Arg 47. In 
contrast, the A146T mutation located in a non-interface region (Figure 6.3b) does not 
appear to have a significant effect on protein-protein interaction. As shown in Table 6.1, 
the binding energy change caused by A146T is ∆∆∆Gbinding = -0.21 kcal/mol, or 
∆∆∆GFoldX = -0.11 kcal/mol. Nevertheless, Ala 146 and its neighboring residues (Leu 15 
and Val 148) may form the hydrophobic pocket, which is involved in the binding of the 
purine ring of GTP/GDP. The substitution of Ala 146 by the polar residue Thr may alter 





Figure 6.3 Illustration of two disease-causing mutations (Q61K and A146T) in human 
HRAS. a) Structural representation of the Q61K mutation. Chains A and B are shown in 
green and yellow, respectively. The residue Gln 61 (wild-type) is shown in red, Lys 61 
(mutant) in blue, and Arg 47 of chain B in cyan. The ydrogen bond is represented as a 
white dash line. b) Structural representation of the A146T mutation. Chains A and B are 
shown in green and yellow, respectively. Ala 146 (wild-type) is shown in magenta, and 
Thr 146 (mutant) in blue. Two neighboring residues, Leu 15 in orange and Val 148 in 
white, are also shown. c) Multiple sequence alignmet of HRAS with the amino acid 
substitution sites indicated. 
 
Application: the A693V substitution in ZBTB20 
The structure-based approach was also used to investigat  the amino acid 
substitution, A693V, in the human ZBTB20 gene (zinc finger and BTB domain 
containing 20). ZBTB20 plays important roles in neurogenesis [40], postnatal survival 
and glucose homeostasis [41]. The A693V substitution is implicated to impair the 
function of ZBTB20 in the brain. Thus, predicting the effects of A693V on protein 
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stability and function may help determine the pathogenic potential of the amino acid 
substitution. 
The structure of the C-terminal region (560-739) of ZBTB20, including five zinc 
finger domains, was constructed using the homology modeling method with the six-
finger zinc finger peptide (PDB: 2I13) as the template. As shown in Figure 6.4a, although 
ZBTB20 may form a homodimer structure, the A693V mutation is not located at the 
interaction interface. The binding energy change caused by A693V is ∆∆∆Gbinding = -0.31 
kcal/mol, or ∆∆∆GFoldX = 0 kcal/mol (Table 6.2), suggesting that the amino acid 
substitution has little effect on dimer formation. The folding energy change was also 
calculated for A693V using TINKER (∆∆Gstability = -2.69 kcal/mol, Table 6.1). In 
addition, all of the structure-based methods predict  that A693V will decrease protein 
stability. Thus, the consensus prediction is that A693V will slightly destabilise the 
monomer structure of ZBTB20. 
Since the ZBTB20 protein was previously shown to bind DNA [40], the structure 
of ZBTB20 in complex with DNA has been modeled using the six-finger zinc finger 
peptide (PDB: 2I13) as the template. As shown in Figure 6.4b, the amino acid residue, 
Ala 693, is located close to the phosphate group of DNA backbone. Therefore, another 
possibility is that the A693V substitution may be involved in protein-DNA interaction. 
The multiple sequence alignment shown in Figure 6.4c also suggests that Ala 693 is 





Figure 6.4 Illustration of the A693V mutation in human ZBTB20. a) Structural 
representation of the A693V mutation. Chains A and B are shown in green and yellow, 
respectively. Ala 693 (wild-type) is shown in magenta, and Val 693 (mutant) in white. b) 
Representation of the modeled structure of ZBTB20 in complex with DNA. Shown are 
chain A in green, Ala 693 in magenta, Val 693 in white, and the DNA molecule as 




In this paper, a structure-based approach is described for assessing the effects of amino 
acid substitutions on protein stability and protein-protein interaction. Homology 
modeling and free energy calculation methods were used to compute the differences of 
folding energy and binding energy between the wild-type and mutant structures. Three 
case studies showed that the disease-causing mutations at the interaction interface might 
reduce the binding energy, and thus weaken the affinity n the protein complex. The 
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pathogenic mutations in the non-interface region could reduce the folding energy and 
thus destabilise the monomer structure. Therefore, the structure-based approach can be 
used to quantitatively assess the effects of amino acid substitutions on protein stability 
and protein-protein interaction. The approach may be useful for understanding the 
molecular mechanisms by which gene mutations cause h man diseases. 
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In the present study, several predictive methods, including machine learning and 
structure modeling approaches, have been developed f r analyzing genes and proteins to 
discover biological knowledge hidden in the heterogneous datasets. Machine learning 
can be used to automatically recognize hidden patterns and make accurate predictions 
based on models derived from complex data. In this study, machine learning approaches 
were developed for identification of human tissue-sp cific genes using microarray gene 
expression data and sequence-based predictions of protein sumoylation sites and protein 
stability changes upon amino acid substitutions. The results suggest that the use of 
relevant biological features for classifier construc ion can improve the classifier 
performance, and the approaches and tools developed in the study can provide valuable 
information for genetic research community. The structure-based approaches were 
developed to quantitatively assess the effects of amino acid substitutions on protein 
stability and protein-protein interaction. It has been shown that pathogenic mutations can 
reduce the folding energy to destabilize the monomer structures and weaken the binding 
affinity to make the complex structures less stable. The machine learning approaches 
together with the structure-based methods were used to analyze candidate genes and 
proteins associated with human genetic disorders such as intellectual disability. 
Genes and proteins play essential roles in almost every biological process within 
the cell. The predictive bioinformatic approaches developed in this study may help 
understand the molecular mechanisms of tissue-specific gene expression, protein 
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sumoylation, protein stability and protein-protein interaction. Tissue-specific genes and 
protein sumoylation targets are implicated in many complex diseases. The amino acid 
substitutions at protein key sites play important roles in many monogenic diseases. 
However, molecular mechanisms underlying the genetic disorders are still poorly 
understood. The methods developed in the present study have been used to analyze 
disease candidate genes and proteins for human genetic studies and the findings may help 
elucidate the molecular mechanisms of some genetic disorders such as intellectual 
disability. The analytical results may also help biomedical scientists to design their 
experiments and to interpret the experimental data. Furthermore, the web servers make 
our computational methods available to the broader sci ntific community. 
The difficulty of predicting protein stability changes upon amino acid 
substitutions with machine learning approaches lies in the rarity of known positive and 
negative examples. Thus, semi-supervised learning methods, such as Self-training, Co-
training, Semi-supervised Support Vector Machines and Graph-based methods, can be 
used to improve the classifier performance with both labeled and unlabeled data in future 
works. Moreover, feature selection approaches, such as Random Forests and Support 
Vector Machine-based Recursive Feature Elimination, can be used to select relevant 
features for classifier construction to enhance the classifier performance. The predictive 
methods developed in this study can be used to analyze intellectual disability candidate 
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Appendix B  
Additional files for predicting human tissue-specific genes 
 
 Additional file B1.  List of brain-specific gene targets. (Supplemental 1) 
 




Additional files for Predicting Protein Sumoylation Sites  
 
Table C.1 The list of 457 experimentally verified sumoylation sites in 263 proteins 
Protein Accession 
(UniProt Entry) 








268 sumoylation sites used by SUMOpre (reported before 08/10/2006) 
Q9H3D4 588 LKIP N 15539951 
Q9H3D4 676 IKEE Y 15539951 
O56136 84 EKGE N 15527853 
O56136 447 FKFE N 15527853 
P19544 73 IKQE Y 15520190 
P19544 177 FKHE N 15520190 
O75030 289 IKRE Y 15507434 
O75030 423 IKQE Y 15507434 
P19532 330 IKRE Y 15507434 
P19484 347 VKQE Y 15507434 
P37231 107* IKVE Y 15229330 
P37231-2 365 PKFE Y 16127449 
Q02447 120 IKDE Y 12419227 
Q02447 551 IKEE Y 12419227 
Q16665 391 LKKE Y 15465032 
Q16665 477 LKLE Y 15465032 
P46060 524 LKSE Y 15355965 
Q14191 496 LKME Y 15355988 
P43694 365 IKTE Y 15337742 
Q08211 76 IKSE Y 15312759 
Q08211 120 LKAE Y 15312759 
P36508 411 VKEE Y 15280358 
Q03188 534 VKSE Y 15272016 
Q03188 721 PKNR N 15272016 
Q03188 746 LKPL N 15272016 
P63279 153 AKKF N 15272016 
P19419 230 LKSE Y 15210726 
P19419 249 VKVE Y 15210726 
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P19419 254 PKEE Y 15210726 
Q9Y4L2 244* VKTE Y 15208321 
Q9Y4L2 263 IKDE Y 15208321 
Q13285 119 FKLE N 15192080 
Q13285 194 IKSE Y 15192080 
P15976 137 LKTE Y 15173587 
P15873 127 LKIE Y 12226657 
P15873 164 TKET N 12226657 
Q05193 376 VKME Y 15123615 
Q60591 684 IKTE Y 15117942 
Q60591 897 VKQE Y 15117942 
P41212 99 TKED N 12626745 
O13066 517* LKSE Y 15094046 
O60812 237 VKME Y 15082759 
P42858 6 EKLM N 15064418 
P42858 9 MKAF N 15064418 
P42858 15 LKSF N 15064418 
P10275 386 IKLE Y 12177000 
P10275 520 VKSE Y 12177000 
Q13485 113 VKYC N 12621041 
Q13485 159 VKDE Y 12621041 
Q03933 82 VKQE Y 11278381 
P78347 221 VKTE Y 15016812 
P78347 240 VKEE Y 15016812 
P78347 456 VKEE Y 15016812 
P78347 991 IKQE Y 15016812 
Q9BYV9 202 EKEE N 15060166 
Q9BYV9 276 IKSE Y 15060166 
Q9BYV9 421 CKQE N 15060166 
Q9BYV9 580 IKCE Y 15060166 
O00429 38 GKSS N 14972687 
Q9Y6K9 277 AKQE Y 14651848 
Q9Y6K9 309 YKAD N 14651848 
Q9UPW6 233 IKVE Y 14701874 
Q9UPW6 350 VKPE Y 14701874 
P06536 297* VKTE Y 14663148 
P06536 313* IKQE Y 14663148 
P25963 21 LKKE Y 14613580 
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P42224 703 IKTE Y 12855578 
P43354 91 IKVE Y 14559918 
P43354 577 LKLE Y 14559918 
Q05516 242 VKTE Y 14527952 
Q9NS56 560 KKEE N 14516784 
P08235 89 IKTE Y 14500761 
P08235 399 IKPE Y 14500761 
P08235 428 IKQE Y 14500761 
P08235 494 IKQE Y 14500761 
P08235 953 LKVE Y 14500761 
Q05397 152 VKSD N 14500712 
P06401 388 IKEE Y 12529333 
Q09472 1020 LKTE Y 12718889 
Q09472 1024 IKEE Y 12718889 
P17676 174 LKAE Y 12810706 
P11831 147 IKME Y 12788062 
Q13363 428 VKPE Y 12679040 
P32457 4 LKEE Y 12149243 
P32457 11 IKQD N 12149243 
P32457 30 IKQE Y 12149243 
P32457 63 VKVE Y 12149243 
P32457 287 AKSD N 12761287 
P32457 443 AKLE Y 12761287 
P32457 465 QKSE N 12761287 
Q12216 438 VKNE Y 12761287 
Q12216 446 VKQE Y 12761287 
Q99497 130 AKDK N 12761214 
P23769 222 MKME Y 12750312 
P23769 389 MKKE Y 12750312 
Q924A0 297 VKQE Y 12727872 
Q00613 298 VKEE Y 11514557 
P10242 503 IKQE Y 12631292 
P10242 527 IKQE Y 12631292 
P36956 123 IKEE Y 12615929 
P36956 418 VKTE Y 12615929 
Q12772 464 VKDE Y 12615929 
P16220 285 RKRE N 12552083 
P16220 304 KKKE N 12552083 
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Q15788 732 IKLE Y 12529333 
Q15788 774 VKVE Y 12529333 
P49715 161 IKQE Y 12511558 
P55854 11* VKTE Y 12506199 
P56817 275 LKMD N 12506199 
P11387 103 IKKE Y 11709553 
P11387 117 IKDE Y 11709553 
P11387 153 IKTE Y 11709553 
P11387 328 IKEE Y 11709553 
P11387 436 IKGE Y 11709553 
Q13547 444 VKTE Y 11960997 
Q13547 476 VKEE Y 11960997 
P27540 245 VKKE Y 12354770 
O15169 857 GKVE N 12223491 
O15169 860 EKVD N 12223491 
Q9NSC2 1086 IKTE Y 12200128 
P49716 120 LKRE Y 12161447 
Q9UER7 630 CKKS N 12150977 
Q9UER7 631 KKSR N 12150977 
P04150 277 VKTE Y 12144530 
P04150 293 IKQE Y 12144530 
P04150 703 VKRE Y 12144530 
P06786 1220 IKLE Y 12086615 
P06786 1246 IKKE Y 12086615 
P06786 1277 IKKE Y 12086615 
P05549 10 IKYE Y 12072434 
Q92481 10* VKYE Y 12072434 
Q15596 239 IKEE Y 12060666 
Q15596 731 IKQE Y 12060666 
Q15596 788 EKEE N 12060666 
P56524 559 VKQE Y 12032081 
Q13569 330* VKEE Y 11889051 
P04637 386 FKTE N 11867732 
P05627 229 LKEE Y 16055710 
P05627 257 IKAE Y 16055710 
P46061 526* LKSE Y 11853669 
P23497 297 IKKE Y 11792325 
P15330-2 382 IKTE Y 11756545 
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P27782 25 FKDE N 11731474 
P27782 267 VKQE Y 11731474 
P29590 65 AKCP N 9756909 
P29590 160 LKHE Y 9756909 
P29590 487 RKVI N 9756909 
P29590 490 IKME Y 9756909 
O15350 627 IKEE Y 10961991 
Q9H2X6 32 LKIE Y 15766567 
Q9H2X6 1191 AKVN N 12149243 
P32458 412 IKQE Y 12149243 
Q07657 426 IKQE Y 12149243 
Q07657 437 IKTE Y 12149243 
P19893 175 IKQE Y 10684265 
P19893 180 IKPE Y 10684265 
P03116 514 IKAP N 11005821 
P13202 450 VKSE Y 11602710 
Q9M0K4 258 KKQE N 11581165 
P03243 104 VKRE Y 11553772 
Q64127 724 IKQE Y 11313457 
Q64127 742 VKQE Y 11313457 
O00541 517 LKLE Y 11071894 
Q6XA64 802 IKSE Y 15105549 
P03206 12 VKFT N 11160742 
P03209 19 IKKQ N 15229220 
P03209 213 SKTG N 15229220 
P03209 517 VKAL N 15229220 
P61086 13 FKEV N 15723079 
P45448 213 LKLE Y 15713642 
P45448 289 IKSE Y 15713642 
P33244-2 418 IKQE Y 15713642 
P57682 10 VKQE Y 15684403 
P57682 198 IKIE Y 15684403 
Q15744 121 VKEE Y 15661739 
Q16514 19 IKPE Y 15637059 
Q15542 14 VKLE Y 15637059 
P04591 474 QKQE N 15613319 
P00445 18 VKFE Y 15596868 
P00445 69 KKTH N 15596868 
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P05750 211 PKEE Y 15596868 
P16649 270 PKEE Y 15596868 
Q07979 322 EKNE N 15596868 
Q07979 328 VKQE Y 15596868 
P04456 60 YKVI N 15542864 
P11978 1128 VKNV N 15542864 
Q04322 498 LKMG N 15542864 
P21538 807 MKTE Y 15542864 
Q14814 439 IKSE Y 15743823 
P41970 162 IKRE Y 15580297 
Q9U1H5 438 IKSE Y 15788563 
Q13422 58 VKVE Y 15767674 
Q13422 241 IKEE Y 15767674 
P06400 720 LKFK N 15806172 
P21063 95 IKIE Y 15800065 
O00180 274 LKKF N 15820677 
P54253 16 KKRE N 15824120 
P54253 194 HKAE N 15824120 
P54253 610 LKID N 15824120 
P54253 697 VKKG N 15824120 
P54253 746 LKFP N 15824120 
P54132 317 SKCL N 15829507 
P54132 331 RKED N 15829507 
P54132 344 SKPE N 15829507 
P54132 347 EKMS N 15829507 
Q8N2W9 35 LKHE Y 15831457 
P42575 77 AKVG N 15882978 
P41161 89 IKRE Y 15857832 
P41161 263 FKQE N 15857832 
P41161 293 IKQE Y 15857832 
P41161 350 VKQE Y 15857832 
O60315 391 IKTE Y 16061479 
O60315 866 IKKE Y 16061479 
P01100 265 LKTE Y 16055710 
O92597 158 VKAE Y 16014952 
P14921 15* IKTE Y 16319071 
Q90YL1 61 LKKE Y 16256735 
Q90YL1 365 IKTE Y 16256735 
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Q8AXX8 52 VKKE Y 16256735 
Q8AXX8 341 VKTE Y 16256735 
P18412 54 VKNE Y 16306045 
Q92793 998 MKTE Y 16287980 
Q92793 1033 VKEE Y 16287980 
Q92793 1056 VKVE Y 16287980 
Q16621 368 TKME N 16287851 
P40381 103 LKWE Y 16168376 
O60016 109 VKKE Y 16168376 
O60016 160 VKEE Y 16168376 
O42934 198 LKWE Y 16168376 
Q8N4C6 1641 LKEE Y 16154161 
Q8N4C6 1680 LKDE Y 16154161 
Q01543 67 VKRE Y 16148010 
Q99683 535 AKQE Y 16142216 
Q99683 1083 LKWE Y 16142216 
Q99683 1114 LKLE Y 16142216 
P55265 418 IKLE Y 16120648 
O00327 259 VKVE Y 16109848 
Q969V6 499 VKEE Y 16098147 
Q969V6 576 VKQE Y 16098147 
Q969V6 624 VKQE Y 16098147 
Q5U0M2 15 IKTE Y 16862185 
Q5U0M2 227 IKQE Y 16862185 
Q86YP4 30 IKME Y 16738318 
Q86YP4 487 AKAE Y 16738318 
Q5VUR2 33 LKME Y 16738318 
O95600 67 IKIE Y 16617055 
Q13426 210 IKQE Y 16478998 
Q06413 391 IKSE Y 16478538 
P10636-8 339 VKSE Y 16464864 
Q9NRA1 314 PKTG N 16443219 
P49792 2571 SKVE N 16194093 
P49792 2592 SKVK N 16194093 
P49792 2650 TKLK N 16194093 
P49792 2723 EKAK N 16194093 
P49792 2725 AKAD N 16194093 
P63165 16 DKKE N 16194093 
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P63165 37 FKVK N 16194093 
P63165 39 VKMT N 16194093 
P63165 46 KKLK N 16194093 
P61956 5* EKPK N 16194093 
P61956 11* VKTE Y 16194093 
P61956 42* SKLM N 16194093 
P06876 499* IKRE Y 16162816 
P06876 523* IKQE Y 16162816 
P12004 164* AKDG N 15931174 
O15151 254 IKVE Y 15907800 
O15151 379 IKKE Y 15907800 
Q07666 96 VKME Y 16568089 
139 sumoylation sites (reported between 08/10/2006 to 01/01/2010) 
P46060 8 AKLA N 15355965 
P63279 14 RKAW N 20424159 
P63279 49 KKGT N 20424159 
P41212 11 IKQE Y 18212042 
O00429 532* DKSS N 19638400 
O00429 535* SKVP N 19638400 
O00429 558* GKLI N 19638400 
O00429 568* TKNV N 19638400 
O00429 594* LKTS N 19638400 
O00429 597* SKAE N 19638400 
O00429 606* EKSK N 19638400 
O00429 608* SKPI N 19638400 
Q05516 387 SKLG N 17498654 
Q05516 396 MKSE Y 17498654 
P55854 41* SKLM N 20029837 
Q16621 215 AKPT N 19966288 
Q16621 234 MKIP N 19966288 
Q16621 241 DKIV N 19966288 
P63165 7 AKPS N 20388717 
P63165 25 LKVI N 20388717 
O95365 61 KKLF N 17595526 
P17544 118 IKEE Y 17264123 
Q8VIM5 573 IKQE Y 17101795 
Q13263 554 VKEE Y 17079232 
Q13263 575 TKPV N 17298944 
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Q13263 676 LKEE Y 17298944 
Q13263 750 EKLS N 17298944 
Q13263 779 DKAD N 17298944 
Q13263 804 TKFS N 17298944 
P04618 115 TKE N 17067581 
Q5U3M4 341 VKEE Y 17060459 
Q99607 657 IKME Y 16904644 
P48432 247 VKSE Y 17097055 
P00441 76 PKDE Y 16828461 
Q13642 144 PKGE Y 17509614 
Q13642 300 VKAP N 17509614 
P20263 118 VKLE Y 17496161 
Q9LSE2 393 VKEE Y 17416732 
Q9UHF7 1201 VKTE Y 17391059 
P25490 288 IKED N 17353273 
P12757 50 VKKE Y 17202138 
P12757 383 IKQE Y 17450299 
Q14526 333 MKHE Y 17283066 
P46099 56 LKSE Y 17938210 
Q04110 5 IKTE Y 17888002 
Q9Y458 63 PKTE Y 17846996 
Q92993 430 LKSE Y 17704809 
Q92993 451 IKKE Y 17704809 
P11474 14 IKAE Y 17676930 
P11474 403 VKLE Y 17676930 
P49841 292 FKFP N 18949077 
P06748 263 PKVE Y 17951246 
P05455 41 IKLD N 17646655 
P54841 32 VKKE Y 17548468 
P54841 297 VKCE Y 17548468 
Q04887 396* IKTE Y 17440973 
P08047 16 VKIE Y 18572193 
Q9WVS8 6 LKEE Y 18467627 
Q9WVS8 22 VKAE Y 18467627 
P43268 96 IKKE Y 18447755 
P43268 226 FKQE N 18447755 
P43268 260 IKQE Y 18447755 
P43268 322 IKQE Y 18447755 
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P43268 441 LKAE Y 18447755 
P06778 126 KKSA N 18396468 
Q64729 391 MKHF N 18469808 
P17275 240 FKEE N 18424718 
Q01826 744 VKLE Y 18408014 
P48552 756 IKSE Y 18211901 
P48552 1154 IKKE Y 18211901 
Q9CAE3 287 IKVE Y 18069938 
Q9CAE3 693 PKAD N 18069938 
Q9CAE3 770 IKAE Y 18069938 
Q9UPG8 250 IKTE Y 17551969 
Q9UPG8 269 VKEE Y 17551969 
Q9UPG8 356 PKVE Y 17551969 
P04050 1487 VKDE Y 19384408 
Q63120 949 IKKE Y 19074644 
Q8CF90 32 VKKE Y 19029092 
Q9UKL0 294 VKKE Y 18854179 
P33242 119* FKLE N 18838537 
P33242 194 IKSE Y 18726511 
P37238 107* IKVE Y 18832723 
Q13887 162 IKTE Y 18782761 
Q13887 209 IKQE Y 18782761 
P05067 662 IKTE Y 18675254 
P05067 670 VKMD N 18675254 
P70671 152 LKDE Y 18635538 
P70434 406 VKLE Y 18635538 
Q15022 72 VKKP N 18628979 
Q15022 73 KKPK N 18628979 
Q15022 75 PKME Y 18628979 
P03120 292 LKGD N 18619639 
Q00653 90 AKIE Y 18617892 
Q00653 298 MKIE Y 18617892 
Q00653 689 LKAG N 18617892 
Q00653 863 VKED N 18617892 
Q71A33 33* VKKE Y 20127678 
Q99814 394 LKEE Y 20026589 
Q19289-2 460 IKLE Y 19922876 
P35187 621 IKRE Y 19906698 
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Q499N1 163 KKKE N 19850744 
Q499N1 168 PKPE Y 19850744 
Q499N1 396 LKME Y 19850744 
Q91ZP3 599 IKEE Y 19753306 
Q91ZP3 629 IKHE Y 19753306 
Q92786 556 IKSE Y 19706680 
P07830 69 LKYP N 19635839 
P07830 285 MKCD N 19635839 
Q9UBK2 184 VKTE Y 19625249 
Q9UKL3 1813 LKSE Y 19615980 
Q07869 185 LKAE Y 19955185 
P17655 390 IKLE Y 19422794 
Q9SJN0 391 LKEE Y 19276109 
A9YTQ3 538 IKME Y 19251700 
A9YTQ3 577 LKTE Y 19251700 
A9YTQ3 660 VKRE Y 19251700 
Q9QWM1 173 MKLE Y 19125815 
Q9QWM1 289* IKSE Y 19125815 
P02545 201 MKEE Y 18606848 
Q9UQ80 93 LKSD N 19946338 
Q9UQ80 298 AKHE Y 19946338 
O13351 14 DKSA N 19707600 
O13351 30 VKPS N 19707600 
Q9UHP3 99 DKDD N 19440361 
Q99856 398 IKKE Y 19436740 
O88275 63 IKPF N 19339015 
O88275 107 IKVE Y 19339015 
Q12692 126 LKVE Y 19217407 
Q12692 133 SKK N 19217407 
Q9QXZ7 178 AKLE Y 19186166 
Q9QXZ7 315 FKPE N 19186166 
Q9QXZ7 322 LKDP N 19186166 
P32333 101 VKLE Y 19139279 
P32333 109 IKLE Y 19139279 
P35398-2 240 IKPE Y 19041634 
Q61164 74 MKTE Y 19029252 
Q61164 698 VKKE Y 19029252 
Q06710 308 IKQE Y 18974227 
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50 sumoylation sites (reported between 01/01/2010 to 06/01/2010) 
Q8R4I1 257 LKST N 19843541 
A2RU29 596 MKSE Y 20501696 
A2RU29 649 VKKE Y 20501696 
A2RU29 650 KKEE N 20501696 
A2RU29 739 VKKE Y 20501696 
A2RU29 793 VKAE Y 20501696 
O35426-2 276 VKIE Y 20408817 
O35426-2 297 VKKE Y 20408817 
Q16666 561 LKTE Y 20388717 
Q9UPN6 18 YKPP N 20388717 
Q9UG01 4 LKHL N 20388717 
Q99518 492 QKQR N 20388717 
Q96QD9 140 RKAN N 20388717 
Q9UBD0 215 VKSA N 20388717 
Q9UBG0 1142 QKPL N 20388717 
Q8IYA6 198 RKPD N 20388717 
O75475 75 RKGF N 20382164 
O75475 250 DKKE N 20382164 
O75475 254 GKKE N 20382164 
O75475 364 LKID N 20382164 
O43290 94 VKRE Y 20346425 
O43290 141 IKKE Y 20346425 
P40337 171 VKPE Y 20300531 
P20193 839 IKVF N 20299342 
P31669 469 IKQE Y 20228053 
P06730 36 IKHP N 20228053 
P06730 49 FKND N 20228053 
P06730 162 DKIA N 20228053 
P06730 206 TKSG N 20228053 
P06730 212 TKNR N 20228053 
O14776 503 IKEE Y 20215116 
O14776 608 IKEE Y 20215116 
P58012 114 IKVP N 20209145 
P58012 150 MKRP N 20209145 
Q92585 217 LKQE Y 20203086 
Q92585 299 IKTE Y 20203086 
P43351 411 MKKR N 20190268 
 170 
P43351 412 KKRK N 20190268 
P43351 414 RKYD N 20190268 
P08069 1055 MKEF N 20145208 
P08069 1130 NKFV N 20145208 
P08069 1150 VKIG N 20145208 
P54843 33 VKKE Y 20127678 
Q15843 27 IKER N 20029837 
Q15843 33 EKEG N 20029837 
Q15843 54 EKTA N 20029837 
Q12306 54 AKRQ N 20029837 
P17844 53 PKFE Y 19995069 
Q92841 50 PKFE Y 19995069 
Q08499-6 323 VKTE Y 20196770 




Table C.2 List of 40 biological features used in chapter three  
Class Feature Abbreviation 
Biochemical Hydrophobicity H 
pKa value  K 
Molecular weight  M 
Size S 
Residue volume V 
Polarity P 
Amino acid composition Co 
Buriability  Br 
Side chain hydropathy, corrected for salvation  Ss 
Scaled side chain hydrophobicity values Hs 
Structural Conformational parameter for alpha helix A 
Conformational parameter for beta sheet  B 
Conformational parameter for beta-turn  T 
Conformational parameter for coil  C 
Buried average area  Aa 
Bulkiness Bu 






Thermodynamic Entropy of formation E 
Transfer free energy Et 
Partition energy Ep 
Short and medium range non-bonded energy per 
residue 
Er 
Average non-bonded energy per residue  En 
Free energy in alpha-helical conformation Ea 
Free energy in beta-strand conformation  Eb 
Solvation free energy Es 
Hydration free energy Eh 
Empirical Stability scale from the knowledge-based atom-
atom potential  
S1 
Relative stability scale extracted from mutation 
experiments 
S2 
Side-chain contribution to protein stability (kJ/mol) S3 
Molar fraction of 3220 accessible residues Fa 
Atomic weight ratio of hetero elements in end 
group to C in side chain  
Rh 
Mobility on chromatography paper Mc 
Other Interactivity scale obtained by maximizing the 
mean of correlation coefficient over single-domain 
globular proteins 
Is 
Side chain volume Vs 
Flexibility F 
Refractivity R 
Number of codons No 
Recognition factors Rf 
Relative mutability Rm 
Transmembrane tendency Tt 
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Appendix D 
Additional data regarding the effect of nsSNPs on binding energy with respect to amino 
acid characteristics 
 
Four different classes of amino acids were considered based on the amino acids’ 
physico-chemical properties: polar (S, T, H, N, Q, Y), charged (E, D, K, R), hydrophobic 
(W, I, L, M, F) and small (P, A, G, C, V). Below we illustrate the effects of nsSNP 
mutations on the ∆∆∆Gtot(snSNP), ∆∆∆Gvdw(nsSNP) and ∆∆∆Gel(nsSNP) (see main body 
of the manuscript for definition of these quantities) separately for each class and between 
classes (Table E.1).  The corresponding distributions are shown in Figure E.1. It can be 
seen that mutations that replace either charged or polar amino acids result in the largest 
energy change, while the effect is much smaller in the cases of small or hydrophobic 
residue replacement.  
Particular attention deserve the 108 cases of nsSNP mutations that retain the 
physico-chemical properties of the amino acid present in the target protein-protein 
complex (case “SAME”, e.g. polarpolar; chargedcharged, smallsmall and 
hydrophobichydrophobic), and another 159 cases in which the nsSNP mutation 
changes the physico-chemical properties of the original amino acid (case “DIFF”) (Table 
B-1). In terms of the means of the distributions, there is no significant difference between 
the “SAME” and “DIFF” distributions. In both cases, the mean of the total binding 
energy and its electrostatic component are negative quantities, which means that in both 
of these cases, the target complex is more stable than the nsSNP variant. At the same 
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time, the mean of the van der Waals energy distribution is positive. The difference is in 
the standard deviation. The standard deviation of the distribution in “SAME” cases is 
about two times smaller than the distribution of “DIFF” cases. This indicates that there 
are cases within the “DIFF” category that result in drastic changes in the binding energy. 
 
Table D.1 Parameters of distribution of total binding energy difference and its 
components 
Group No ∆∆∆Gtot ∆∆∆Gvdw ∆∆∆Gel 
mean std mean std mean std 
All 264 -0.86 4.28 -0.05 3.11 -0.78 4.64 
OMIM 45 -1.65 3.80 -1.03 3.32 -2.35 5.51 
Non-OMIM 219 -0.70 4.36 0.14 3.03 -0.45 4.39 
Polar (P) 62 -0.27 3.77 0.38 3.94 -0.83 4.74 
P-C 20 0.05 5.58 1.98 6.35 -3.00 7.59 
P-H 7 -1.76 3.16 0.54 0.54 -0.66 1.37 
P-P 28 -0.29 2.58 -0.50 1.73 0.35 2.07 
P-S 7 0.37 1.46 -0.75 1.79 0.44 0.85 
Charge (C) 76 -2.01 6.38 -0.33 2.25 -1.37 6.59 
C-C 25 -2.16 3.59 -0.45 1.77 -1.76 3.99 
C-P 30 -1.03 7.52 0.24 1.68 -0.38 8.53 
C-H 3 -5.84 6.23 1.76 2.01 -1.11 10.86 
C-S 18 -2.80 6.80 -1.45 0.74 -2.51 5.26 
Small (S) 94 -0.74 2.39 -0.03 2.49 -0.78 2.58 
S-C 10 0.56 2.72 2.51 3.58 -4.79 4.39 
S-H 31 0.04 1.57 0.27 1.83 0.38 1.23 
S-P 20 -0.88 1.53 0.01 1.37 -0.81 2.16 
S-S 33 -1.79 2.92 -1.11 2.61 -0.65 1.85 
Hydrophobic (H) 32 0.32 2.50 -0.36 4.46 0.74 3.23 
H-C 2 -1.40 0.51 -0.90 0.33 -3.14 0.07 
H-H 19 0.35 1.72 -0.39 1.70 -0.26 1.13 
H-P 5 0.56 3.65 2.10 9.45 5.14 5.93 
H-S 6 0.60 4.01 -2.14 5.61 1.55 1.40 
SAME 108 -1.09 2.97 -0.66 2.05 -0.57 2.58 
DIFF 159 -0.72 4.96 0.34 3.60 -0.91 5.61 
Conserved 139 -0.85 4.94 -0.07 3.71 -1.05 5.55 
Non-Conserved 88 -0.83 3.51 0.06 2.15 -0.72 3.38 
High Conserved 176 -0.93 4.84 -0.10 3.45 -1.11 5.16 
Low Conserved 51 -0.53 2.58 0.27 2.11 -0.26 3.38 
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Figure D.1 Distribution of ∆∆∆Gtot(nsSNP), ∆∆∆Gel(nsSNP) and ∆∆∆Gvdw(nsSNP) in 
respect with physico-chemical properties of amino acids. T: total, P: polar, C: charged, S: 
small, H: hydrophobic. The thick black lines show the median, the boxes are drawn 
between upper and down quartiles and the dotted lines are extended to upper and down 
whiskers (marked with short horizontal lines). 
 
